# Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by Karenia spp. and Their Metabolic Products in Marine Organisms

Vincent Hort, Eric Abadie, Nathalie Arnich, Marie-Yasmine Dechraoui

Bottein, Zouher Amzil

► To cite this version:

Vincent Hort, Eric Abadie, Nathalie Arnich, Marie-Yasmine Dechraoui Bottein, Zouher Amzil. Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by Karenia spp. and Their Metabolic Products in Marine Organisms. Marine drugs, 2021, 19 (12), pp.656-10.3390/md19120656. anses-03549777

HAL Id: anses-03549777

https://anses.hal.science/anses-03549777

Submitted on 26 Aug 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Review

# Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by *Karenia* spp. and Their Metabolic Products in Marine Organisms

Vincent Hort<fnref n="1" />,*, Eric Abadie<fnref n="2" />,*, Nathalie Arnich<fnref n="3" />, Marie-Yasmine Dechraoui Bottein<fnref n="4" />,<fnref n="5" /> and Zouher Amzil<fnref n="6" />,*

<figure><img src="image_3.png" /></figure>

check for
updates

**Citation:** Hort, V.; Abadie, E.; Arnich, N.; Dechraoui Bottein, M.-Y.; Amzil, Z. Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by *Karenia* spp. and Their Metabolic Products in Marine Organisms. *Mar. Drugs* **2021**, *19*, 656.

https://doi.org/10.3390/md19120656

Academic Editors: M.
Carmen Louzao and Natalia Vilariño

Received: 18 October 2021
Accepted: 18 November 2021

Published: 24 November 2021

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_4.png" /></figure>

**Copyright:** © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

**Abstract:** In recent decades, more than 130 potentially toxic metabolites originating from dinoflagellate species belonging to the genus *Karenia* or metabolized by marine organisms have been described. These metabolites include the well-known and large group of brevetoxins (BTXs), responsible for foodborne neurotoxic shellfish poisoning (NSP) and airborne respiratory symptoms in humans. *Karenia* spp. also produce brevenal, brevisamide and metabolites belonging to the hemi-brevetoxin, brevisin, tamulamide, gymnocin, gymnodimine, brevisulcenal and brevisulcatic acid groups. In this review, we summarize the available knowledge in the literature since 1977 on these various identified metabolites, whether they are produced directly by the producer organisms or biotransformed in marine organisms. Their structures and physicochemical properties are presented and discussed. Among future avenues of research, we highlight the need for more toxin occurrence data with analytical techniques, which can specifically determine the analogs present in samples. New metabolites have yet to be fully described, especially the groups of metabolites discovered in the last two decades (e.g tamulamides). Lastly, this work clarifies the different nomenclatures used in the literature and should help to harmonize practices in the future.

**Keywords:** *Karenia* spp.; marine biotoxins; brevetoxins; metabolic products; shellfish; marine organisms

## 1. Introduction

The genus *Karenia* belongs to the clade of the alveolates (with the ciliates and the apicomplexa). It includes 12 known marine species from oceanic and coastal areas. These eukaryotes were formerly classified as microalgae, and belong to the group of photosynthetic protists (autotrophs) [1]. Among the genus *Karenia*, some species of this dinoflagellate can proliferate and form dense blooms that cause multiple dysfunctions of the hydrosystem, but also have a strong toxic potential for organisms in the food web [2,3]. These massive blooms, referred as “red tides”, can be visible and color the water. Brevetoxins (BTXs), which are produced by *Karenia brevis* (C.C. Davis) Gert Hansen and Moestrup, 2000, belong to the main group of marine biotoxins associated with these events. These neurotoxins can cause significant mortality in fish, sea birds, and marine mammals [4–6]. Humans can also be exposed to BTX through food, leading to human

<footnote n="1">¹ Laboratory for Food Safety, Pesticides and Marine Biotoxins Unit, ANSES (French Agency for Food, Environmental and Occupational Health and Safety), 94701 Maisons-Alfort, France</footnote>

<footnote n="2">² MARBEC (MARine Biodiversity, Exploitation and Conservation), Université de Montpellier, CNRS, Ifremer, IRD, 34200 Sète, France; eric.abadie@ifremer.fr</footnote>

<footnote n="3">³ Risk Assessment Directorate, ANSES (French Agency for Food, Environmental and Occupational Health and Safety), 94701 Maisons-Alfort, France; nathalie.arnich@anses.fr</footnote>

<footnote n="4">⁴ Université Côte d'Azur, CNRS, UMR 7035 ECOSEAS, 06103 Nice, France;
marie-yasmine.bottein@univ-cotedazur.fr</footnote>

<footnote n="5">⁵ Federative Research Institute—Marine Ressources, Université Côte d'Azur, CNRS, 06108 Nice, France</footnote>

<footnote n="6">⁶ Ifremer (French Research Institute for Exploitation of the Sea), 44311 Nantes, France</footnote>

<footnote>* Correspondence: vincent.hort@anses.fr (V.H.); zouher.amzil@ifremer.fr (Z.A.); Tel.: +33-1-4977-4671 (V.H.); +33-2-4037-4069 (Z.A.)</footnote>
poisoning, called neurotoxic shellfish poisoning (NSP), inhalation or contact (skin or mucous membranes) [7,8]. Shellfish consumption is the main cause of NSP. Symptoms of NSP include nausea, vomiting, diarrhea, paresthesia, cramps, bronchoconstriction, paralysis, seizures and coma. Inhalation or contact exposure can result in irritant effects. To date, NSP events have been limited to the Gulf of Mexico, the east coast of the United States of America (U.S.A.), and New Zealand [9]. No cases of NSP have been reported in Europe to date; however, a recent study has shown the presence of these toxins in shellfish from the French Mediterranean Sea, raising the question of the potential emergence of this group of toxins in areas that have been preserved to date [10,11]. *Karenia* spp. can also produce the following groups of potentially toxic metabolites in addition to the BTXs: hemibrevetoxins, brevenals, brevisamides, brevisins, tamulamides, gymnocins, gymnodimines, brevisucenals, and brevisulcatic acids [12].

The use of systematic nomenclature to refer to these metabolites is cumbersome, considering their molecular weight and the large number of analogs. In recent decades, different nomenclatures have been used to name the toxins produced by *Karenia* spp., leading to a large number of names, sometimes for the same analog, especially for brevetoxins. One reason for this proliferation of names is that isolation and toxicology studies were sometimes carried out from the causative organisms, before pure materials were available and the structures of the metabolites were elucidated [13]. Moreover, one of the earliest nomenclatures was based on the name of the producer identified at that time: *Gymnodinium breve* C.C. Davis, 1948. For example, "GB-1 toxin" was the name attributed to BTX-1. In 1979, *Gymnodinium breve* was taxonomically reclassified to *Ptychodiscus brevis* (C.C. Davis) K.A.Steidinger, 1979. This change led to a nomenclature revision of brevetoxins, which became *Ptychodiscus brevis* toxins, with the abbreviation PbTx [14]. Eventually, in 2000, the brevetoxin producer was named *Karenia brevis* (*K. brevis*) by Hansen and Moestrup [15]. The term brevetoxin is the only name that has withstood the test of time. BTX is now widespread and taken up not only for recently isolated metabolites, but also for the first discovered metabolites, which were initially named following another nomenclature [10,11,16–19]. Despite the harmonization of the term BTX, several analogs with different names are still encountered, for several other reasons. Moreover, we should recall that this abbreviation is also shared with the batrachotoxins, a small group of steroidal alkaloids.

Considering all the different groups of metabolites produced by *Karenia* spp., accumulation and biotransformation by marine organisms has been investigated in depth for BTXs and gymnodimines (GYMs), contrary to the other groups [4,17,18,20–47]. In 1992–1993, a major NSP outbreak occurred in New Zealand after a *K. brevis* bloom. A total of 180 people were intoxicated after shellfish consumption, with a toxin profile dominated by the analogue BTX-2. An analysis of the shellfish samples collected during this NSP event, combined with the implementation of specific analytical methods (particularly physicochemical techniques), led to the first evidence suggesting BTX metabolism in shellfish [20,21,31,33,36–38,40]. BTX-2, BTX-3 and BTX-B5, known to be produced by *K. brevis*, were detected in cockles, mussels and oysters collected during this event (*Austrovenus stutchburyi*, *Perna canaliculus* and *Crassostrea gigas*, respectively) [20,21,31,33]. Metabolites that were not identified from *K. brevis* natural blooms or cultures at that time were also isolated from these shellfish, particularly amino acid conjugates (taurine-BTX-B and cysteine-BTX-B sulfoxide, also called BTX-B1 and BTX-B2, respectively) and fatty acid conjugates (oxidized open D-ring tetradecanoyl-BTX-2 and oxidized open D-ring hexadecanoyl-BTX-2), and sometimes a combination of these transformations (N-tetradecanoyl-cysteine-BTX-B sulfoxide, also called BTX-B4). These preliminary results suggested the metabolism processes of BTXs in shellfish, and further investigations followed, with different shellfish species and other marine organisms either naturally exposed to *K. brevis*, in cultures, or to pure toxins [17,22,23,30,34,35,39,48–50]. BTX profiles varied depending on the species due to different rates of accumulation and elimination. Consequently, their toxicity fluctuates over time, based on the toxin profile. These studies also allowed for the identification
of numerous new metabolites. For many of them, chemical structure elucidation relied
on a stringent study of their mass spectrometry fragmentation profiles. Confirmation of
these structures with more thorough elucidation tools, such as nuclear magnetic resonance
(NMR), would require large quantities of samples for isolation and purification purposes,
making this goal difficult to achieve.

The aim of this review is to summarize the knowledge collected in recent decades
about the potentially toxic metabolites produced by *Karenia* spp. or reported in other
marine organisms. Therefore, metabolites obtained by chemical synthesis (partially or
fully from existing compounds) or from *in vitro* metabolism studies will not be consi
dered [51–55]. We will present and discuss the structures and physicochemical properties
of the metabolites reported in the literature. The accumulation and biotransformation of
these potentially toxic metabolites by marine organisms will be discussed in depth and will
help to identify and highlight future avenues of research. As previously mentioned, the use
of different nomenclatures can be disruptive and it is not always easy to switch between
the different names used, especially for BTXs. We will tackle this aspect by reporting all
the names used in the literature and by preferentially using those which seem to achieve a
better overall consistency.

## 2. Metabolites Produced by *Karenia* spp.

Among the different *Karenia* species reported, *K. brevis* is known to produce BTXs, bre-
visin, brevisamide, brevenals and tamulamides, whereas brevisulcenals and brevisulcatic
acids can be produced by *Karenia brevisulcata* (F.H. Chang, 1999) G. Hansen & Moestrup,
2000. Gymnocins and gymnodimine-A were discovered from cultures of *Karenia miki-
motoi* (Miyake & Kominami ex Oda) G. Hansen & Moestrup, 2000 [24,56–58], whereas
gymnodimine-B and -C were first isolated from *Karenia selliformis* A.J. Haywood, K.A.
Steidinger & L. MacKenzie, 2004 [59]. All these groups of metabolites possess different
structure skeletons that give them their physicochemical properties (Table 1). To allow for
a better follow-up of the numerous compounds reported in this review, an identification
number (ID) was attributed to each of them in the following parts of this article (text, tables
and figures).
<table><caption>**Table 1.** Physicochemical properties of brevetoxins (BTXs) and other potentially toxic metabolites produced by *Karenia* species.</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Species</th><th>First Identification/Structural Elucidation References</th></tr></thead><tbody><tr><td rowspan="7">A-type brevetoxins (BTX-A)</td><td>#1</td><td>BTX-1</td><td>PbTx-1; GB-1; T46, BTX-A</td><td>C<sub>49</sub>H<sub>70</sub>O<sub>13</sub></td><td>866.5</td><td>5.8</td><td>K. brevis</td><td>[60]</td></tr><tr><td>#2</td><td>BTX-7</td><td>PbTx-7; GB-7; Aldehyde-reduced PbTx-1</td><td>C<sub>49</sub>H<sub>72</sub>O<sub>13</sub></td><td>868.5</td><td>5.7</td><td>K. brevis</td><td>[60]</td></tr><tr><td>#3</td><td>BTX-10</td><td>/</td><td>C<sub>49</sub>H<sub>74</sub>O<sub>13</sub></td><td>870.5</td><td>5.5</td><td>K. brevis</td><td>[13,61]<sup>2</sup></td></tr><tr><td>#4</td><td>Oxidized BTX-1</td><td>Oxidized PbTx-1</td><td>C<sub>49</sub>H<sub>70</sub>O<sub>14</sub></td><td>882.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td>#5</td><td>Open A-ring BTX-1</td><td>Open-ring PbTx-1</td><td>C<sub>49</sub>H<sub>72</sub>O<sub>14</sub></td><td>884.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td>#6</td><td>Open A-ring, oxidized BTX-1</td><td>Open-ring, oxidized PbTx-1; PbTx-1-open ring-carboxylic acid</td><td>C<sub>49</sub>H<sub>72</sub>O<sub>15</sub></td><td>900.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td>#7</td><td>Open A-ring BTX-7</td><td>Open-ring PbTx-7</td><td>C<sub>49</sub>H<sub>74</sub>O<sub>14</sub></td><td>886.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td rowspan="10">B-type brevetoxins (BTX-B)</td><td>#8</td><td>BTX-2</td><td>PbTx-2; T47; GB-2, T34, BTX-B</td><td>C<sub>50</sub>H<sub>70</sub>O<sub>14</sub></td><td>894.5</td><td>6.4</td><td>K. brevis</td><td>[62–64]</td></tr><tr><td>#9</td><td>BTX-3</td><td>PbTx-3; GB-3; T17; Dihydro-BTX-B; Aldehyde-reduced PbTx-2</td><td>C<sub>50</sub>H<sub>72</sub>O<sub>14</sub></td><td>896.5</td><td>6.4</td><td>K. brevis</td><td>[65,66]</td></tr><tr><td>#10</td><td>BTX-5</td><td>PbTx-5; GB-5; acetylated PbTx-2</td><td>C<sub>52</sub>H<sub>72</sub>O<sub>15</sub></td><td>936.5</td><td>7.1</td><td>K. brevis</td><td>[67]</td></tr><tr><td>#11</td><td>BTX-6</td><td>PbTx-6; GB-6; 27,28 epoxyde of PbTx-2</td><td>C<sub>50</sub>H<sub>70</sub>O<sub>15</sub></td><td>910.5</td><td>7.3</td><td>K. brevis</td><td>[67]</td></tr><tr><td>#12</td><td>BTX-9</td><td>PbTx-9; α-methylene reduced PbTx-3</td><td>C<sub>50</sub>H<sub>74</sub>O<sub>14</sub></td><td>898.5</td><td>6.3</td><td>K. brevis</td><td>[13,14,61]</td></tr><tr><td>#13</td><td>BTX-B5</td><td>Oxidized BTX-2; Oxidized PbTx-2</td><td>C<sub>50</sub>H<sub>70</sub>O<sub>15</sub></td><td>910.5</td><td>/</td><td>K. brevis</td><td>[32,33,35]</td></tr><tr><td>#14</td><td>Open A-ring BTX-2</td><td>Open A-ring PbTx-2</td><td>C<sub>50</sub>H<sub>72</sub>O<sub>15</sub></td><td>912.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td>#15</td><td>Open A-ring, oxidized BTX-2</td><td>Open A-ring, Oxidized PbTx-2; Open A-ring BTX-B5; PbTx-2-open ring-carboxylic acid</td><td>C<sub>50</sub>H<sub>72</sub>O<sub>16</sub></td><td>928.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td>#16</td><td>Open A-ring BTX-3</td><td>Open A-ring PbTx-3</td><td>C<sub>50</sub>H<sub>74</sub>O<sub>15</sub></td><td>914.5</td><td>/</td><td>K. brevis</td><td>[35]<sup>3</sup></td></tr><tr><td rowspan="3">Hemi-Brevetoxins (Hemi-BTXs)</td><td>#17</td><td>Hemi-BTX-A</td><td>GB-M</td><td>/</td><td>/</td><td>/</td><td>K. brevis</td><td>[68,69]</td></tr><tr><td>#18</td><td>Hemi-BTX-B</td><td>GB-N</td><td>C<sub>28</sub>H<sub>42</sub>O<sub>7</sub></td><td>490.3</td><td>3.5</td><td>K. brevis</td><td>[69]</td></tr><tr><td>#19</td><td>Hemi-BTX-C</td><td>GB-4</td><td>/</td><td>/</td><td>/</td><td>K. brevis</td><td>[69]</td></tr><tr><td rowspan="2">Brevenals</td><td>#20</td><td>Brevenal</td><td>/</td><td>C<sub>39</sub>H<sub>60</sub>O<sub>8</sub></td><td>656.4</td><td>6.9</td><td>K. brevis</td><td>[70]</td></tr><tr><td>#21</td><td>Dimethyl acetal brevenal</td><td>/</td><td>C<sub>41</sub>H<sub>66</sub>O<sub>9</sub></td><td>702.5</td><td>/</td><td>K. brevis</td><td>[70]</td></tr></tbody></table>
<table><caption>Table 1. *Cont.*</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Species</th><th>First Identification/Structural Elucidation References</th></tr></thead><tbody><tr><td>Brevisamide</td><td>#22</td><td>Brevisamide</td><td>/</td><td>C<sub>18</sub>H<sub>29</sub>NO<sub>4</sub></td><td>323.2</td><td>/</td><td>K. brevis</td><td>[71]</td></tr><tr><td>Brevisin</td><td>#23</td><td>Brevisin</td><td>/</td><td>C<sub>39</sub>H<sub>62</sub>O<sub>11</sub></td><td>706.4</td><td>3.6</td><td>K. brevis</td><td>[72]</td></tr><tr><td rowspan="2">Tamulamides (Tams)</td><td>#24</td><td>Tam-A</td><td>/</td><td>C<sub>35</sub>H<sub>45</sub>NO<sub>10</sub></td><td>639.3</td><td>1.0</td><td>K. brevis</td><td>[73]</td></tr><tr><td>#25</td><td>Tam-B</td><td>/</td><td>C<sub>34</sub>H<sub>43</sub>NO<sub>10</sub></td><td>625.3</td><td>0.7</td><td>K. brevis</td><td>[73]</td></tr><tr><td rowspan="4">Gymnocins</td><td>#26</td><td>Gymnocin-A</td><td>/</td><td>C<sub>55</sub>H<sub>80</sub>O<sub>18</sub></td><td>1028.5</td><td>3.3</td><td>K. mikimotoi</td><td>[56]</td></tr><tr><td>#27</td><td>Gymnocin-A carboxylic acid</td><td>/</td><td>C<sub>55</sub>H<sub>80</sub>O<sub>19</sub></td><td>1044.5</td><td>3.6</td><td>K. mikimotoi</td><td>[58]</td></tr><tr><td>#28</td><td>Gymnocin-A2</td><td>/</td><td>C<sub>55</sub>H<sub>80</sub>O<sub>18</sub></td><td>1028.5</td><td>/</td><td>K. mikimotoi</td><td>[58]</td></tr><tr><td>#29</td><td>Gymnocin-B</td><td>/</td><td>C<sub>62</sub>H<sub>92</sub>O<sub>20</sub></td><td>1156.6</td><td>5.0</td><td>K. mikimotoi</td><td>[57]</td></tr><tr><td rowspan="3">Gymnodimines (GYMs)</td><td>#30</td><td>GYM-A</td><td>/</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>4</sub></td><td>509.4</td><td>6.4</td><td>K. mikimotoi</td><td>[24]</td></tr><tr><td>#31</td><td>GYM-B</td><td>/</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>5</sub></td><td>523.3</td><td>5.1</td><td>K. selliformis</td><td>[74]</td></tr><tr><td>#32</td><td>GYM-C</td><td>GYM-B isomer</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>5</sub></td><td>523.3</td><td>/</td><td>K. selliformis</td><td>[59]</td></tr><tr><td rowspan="4">Brevisucenals (KBTs)</td><td>#33</td><td>KBT-A1 (sodium salt)</td><td>KBT-F sulfate ester</td><td>C<sub>107</sub>H<sub>159</sub>O<sub>41</sub>SNa</td><td>2155.0</td><td>/</td><td>K. brevisulcata</td><td>[75]</td></tr><tr><td>#34</td><td>KBT-A2 (sodium salt)</td><td>KBT-G sulfate ester</td><td>C<sub>108</sub>H<sub>161</sub>O<sub>42</sub>SNa</td><td>2185.0</td><td>/</td><td>K. brevisulcata</td><td>[75]</td></tr><tr><td>#35</td><td>KBT-F</td><td>/</td><td>C<sub>107</sub>H<sub>160</sub>O<sub>38</sub></td><td>2053.1</td><td>7.9</td><td>K. brevisulcata</td><td>[76,77]</td></tr><tr><td>#36</td><td>KBT-G</td><td>/</td><td>C<sub>108</sub>H<sub>162</sub>O<sub>39</sub></td><td>2083.1</td><td>/</td><td>K. brevisulcata</td><td>[77,78]</td></tr><tr><td rowspan="2">Brevisulcatic acids (BSXs)</td><td>#37</td><td>KBT-H</td><td>/</td><td>C<sub>107</sub>H<sub>160</sub>O<sub>39</sub></td><td>2069.1</td><td>/</td><td>K. brevisulcata</td><td>[78]</td></tr><tr><td>#38</td><td>KBT-I</td><td>/</td><td>C<sub>108</sub>H<sub>162</sub>O<sub>40</sub></td><td>2099.1</td><td>/</td><td>K. brevisulcata</td><td>[78]</td></tr><tr><td rowspan="3">Brevisulcatic acids (BSXs)</td><td>#39</td><td>BSX-1</td><td>/</td><td>C<sub>49</sub>H<sub>72</sub>O<sub>16</sub></td><td>916.5</td><td>3.6</td><td>K. brevisulcata</td><td>[77,79]</td></tr><tr><td>#40</td><td>BSX-2</td><td>/</td><td>C<sub>47</sub>H<sub>68</sub>O<sub>15</sub></td><td>872.5</td><td>/</td><td>K. brevisulcata</td><td>[77,80]</td></tr><tr><td>#41</td><td>BSX-3</td><td>/</td><td>/</td><td>856.5</td><td>/</td><td>K. brevisulcata</td><td>[77] <sup>4</sup></td></tr></tbody></table>
<table><caption>Table 1. *Cont.*</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Species</th><th>First Identification/Structural Elucidation References</th></tr></thead><tbody><tr><td></td><td>#42</td><td>BSX-4</td><td>/</td><td>C<sub>49</sub>H<sub>70</sub>O<sub>15</sub></td><td>898.5</td><td>3.8</td><td>K. brevisulcata</td><td>[68,79]</td></tr><tr><td></td><td>#43</td><td>BSX-5</td><td>/</td><td>C<sub>47</sub>H<sub>66</sub>O<sub>14</sub></td><td>854.4</td><td>/</td><td>K. brevisulcata</td><td>[77,80]</td></tr><tr><td></td><td>#44</td><td>BSX-6</td><td>Lactone derivative of BSX-3</td><td>/</td><td>838.5</td><td>/</td><td>K. brevisulcata</td><td>[77] <sup>4</sup></td></tr><tr><td></td><td>#45</td><td>BSX-7</td><td>/</td><td>C<sub>47</sub>H<sub>70</sub>O<sub>14</sub></td><td>858.5</td><td>/</td><td>K. brevisulcata</td><td>[80]</td></tr></tbody></table>

<footnote n="1">¹ LogP predicted from the chemical structure of molecules using the ACD/Labs platform. Octanol/water partition coefficients were predicted using algorithms. ² Synthesized toxin, unidentified in cultures to date, but postulated to occur naturally, based on structural correlation with BTX-9 and its presence in stationary cultures. ³ Analogs postulated after thorough study of LC-MS/MS fragmentations. ⁴ Structure not elucidated.</footnote>
The implementation of specific methods for the analysis of metabolites produced by *Karenia* spp. allowed for the identification of individual analogs belonging to several of these groups of toxins in Australia, Japan, New Zealand, the Gulf of Mexico and the South China Sea (Figure 1) [16,35,45–47,56,64,75–77,81,82].

<figure><img src="image_5.png" /><figcaption>**Figure 1.** Geographical distribution of potentially toxic metabolites individually and formally identified (blue color for country), displayed by type of samples collected (forms) and by group to which they belong (colors of forms). Map generated using R software and the ggplot2 package [83,84].</figcaption></figure>

## 2.1. *Brevetoxins*

BTXs are lipid-soluble and thermostable polycyclic polyethers produced by the dinoflagellate *Karenia brevis* [13]. In laboratory conditions, the production of BTX-2 (ID #8) has also been shown for *Karenia papilionacea* A.J. Haywood and K.A. Steidinger, 2004 [85]. These toxins are polyethers with ladder-like structures similar to ciguatoxins (CTXs) (produced by the dinoflagellate *Gamberdiscus*). All polyether compounds produced by *K. brevis* are thought to derive from polyepoxide precursors [86,87]. A wide range of BTXs have been identified from *K. brevis* cultures (Table 1). NMR and X-ray crystallography were the analytical techniques implemented to establish their structures. A-type and B-type BTXs (BTX-A and BTX-B) are the two base skeletons identified (Figure 2). BTX-1 (ID #1) and BTX-2 are the parent algal toxins of the BTX-A and BTX-B types, respectively [88]. The molecular formula of BTX-1 is C₄₉H₇₀O₁₃ and its structure is composed of 10 rings [60,66]. The molecular formula of BTX-2 is C₅₀H₇₀O₁₄ and its structure is composed of 11 rings [14,64]. Both structures carry a lactone function that is thought to be responsible for their biological activity [88]. BTX-2 is the major toxin isolated from *K. brevis* and the one produced by the largest number of species of the genus *Karenia* [88].

The structural elucidation of BTX-1 (ID #1) and BTX-2 (ID #8) facilitated the resolution of the structure of all subsequently discovered all related analogs (Figure 2). Each family consists of several compounds, differentiated by the “J-ring” in BTX-A (BTX-1, BTX-7, BTX-10 with respective ID of #1, #2, #3) and at the “K-ring” in BTX-B (BTX-2, BTX-3, BTX-5, BTX-6, BTX-9 with respective ID of #8, #9, #10, #11, #12) [13,14,35,60,61,65–67,89]. These different metabolites are reduced, acetylated or epoxidized forms of BTX-1 (ID #1) or BTX-2 (ID #2). Other analogs have been identified from *K. brevis* cultures and natural blooms, and correspond to the oxidized forms of BTX-1 (ID #4) and BTX-2 (BTX-B5, ID #13), and to the open forms of the first ring (A-ring) of BTX-1 (ID #5), BTX-2 (ID #14), BTX-3 (ID #16) and BTX-7 (ID #7) [35]. Open forms of oxidized BTX-1 (ID #6) and BTX-2 (ID #15) have also
been reported (Figure 2). The structures of these open A-ring derivatives were postulated after a thorough study of their tandem mass spectrometry (MS/MS) fragmentations, but could not be elucidated with powerful techniques such as NMR. It is worth noting that some of these open A-ring derivatives were identified with greater abundance than their non-hydrolyzed counterparts.

In 2005, BTX-11 (ID #46), BTX-12 (ID #47) and BTX-tbm (BTX-2 decomposition product without the side chain tail; ID #48) were described as new toxins after their identification in cultures and in the field (Figure 2) [88,90]. Since then, these toxins were never detected. Moreover, several compounds initially identified as BTXs are now considered artifacts (not included in Table 1). BTX-8 (C₄₉H₆₉ClO₁₄; also called BTX-C; ID #49) is generated during chloroform extraction of BTX-2 (ID #8) from *K. brevis* [35,88,91]. BTX-13 (ID #50) and BTX-14 (ID #51) are likely artifacts of acid-catalyzed methanol addition during purification protocols [88].

BTXs are neurotoxins that primarily target the voltage-gated Na+ channels (NaV) [11]. The neurological nature of the primarily symptoms observed in humans and animals can be explained by the specific affinity of BTXs for NaV channel subtypes and the tissue distribution of NaV channels. The symptoms also involve gastrointestinal and cardiovascular systems. Data on acute toxicity in animals are very limited. The only toxicity study by oral administration allows for an estimation of the median lethal doses (LD₅₀) for BTX-2 and BTX-3 in female mice [14]. BTX-3 was about 10 times more toxic than BTX-2 by oral administration, with LD₅₀ of 520 and 6600 µg/kg bw, respectively. However, by intraperitoneal injection, the two toxins were almost equipotent.

## 2.2. Hemibrevetoxins

Hemibrevetoxins (Hemi-BTX-A, -B, -C with respective ID of #17, #18, #19), cyclic ethers biosynthesized by *K. brevis*, were first isolated by Shimizu [68] in 1982 and were reported to have weak ichthyotoxicity. Later, Prasad and Shimizu elucidated the chemical structure of Hemi-BTX-B [69] (Figure 3). Its molecular formula is C₂₈H₄₂O₇, and is about half that of BTXs, hence its name (Table 1). The authors suggested that hemibrevetoxins could play an important role in the biosynthesis of BTXs. They also noted cytotoxicity at a concentration of 5 µmol on cultured mouse neuroblastoma cells, and a characteristic rounding of cells, as for BTX-A and BTX-B. Hemi-BTX-A and -C were isolated; however, their chemical structures seem to have never been fully elucidated [68,69].

## 2.3. Brevenals

In 2004, brevenal (ID #20) and its dimethyl acetal (ID #21) were first isolated and characterized from *K. brevis* cells collected in Florida, USA (Figure 4). These fat-soluble compounds, with molecular formulae C₃₉H₆₀O₈ and C₄₁H₆₆O₉, respectively, are composed of five ether rings and possess an aldehyde function [16,70,81]. Brevenals are not toxic for fish and antagonize the effects of BTXs. Both competitively displace BTX from its binding site in rat brain synaptosomes. Moreover, brevenal inhibits the bronchoconstriction induced by BTX-2 (ID #8) and BTX-3 (ID #9) in a sheep assay [90]. In 2006, the first synthesis of brevenal was accomplished [92]. This work led to a revision of the structure of brevenal, which corresponds to the C26 epimer of the initially proposed natural product structure (Figure 4).

## 2.4. Brevisamide

In 2008, brevisamide (ID #22) was isolated from *K. brevis* [71]. Its molecular formula is C₁₈H₂₉NO₄ and its structure is composed of a monocyclic ether possessing an amide function. It is also composed of a tetrahydropyran ring bearing a 3,4-dimethylhepta-2,4 dienal side chain (Figure 5). To date, no other analog has been discovered. Brevisamide was synthetized by several authors using different strategies [93–95]. Brevisamide may be the biosynthetic precursor of brevisin, based on their respective structures [95]. The toxicity of this metabolite remains unknown, due to the absence of any studies.
## Brevetoxin-A backbone

<figure><img src="image_6.png" /></figure>

## Brevetoxin-B backbone

<figure><img src="image_7.png" /><figcaption>**Figure 2.** Chemical structures of brevetoxins (BTXs) identified from environmental samples and cultures of *Karenia brevis*.</figcaption></figure>
<figure><img src="image_8.png" /><figcaption>**Figure 3.** Chemical structure of hemibrevetoxin-B (ID #18).</figcaption></figure>

<figure><img src="image_9.png" /><figcaption>**Figure 4.** Chemical structures of brevenal (ID #20) and dimethyl acetal brevenal (ID #21).</figcaption></figure>

<figure><img src="image_10.png" /><figcaption>**Figure 5.** Chemical structure of brevisamide (ID #22).</figcaption></figure>

## 2.5. Brevisin

In 2009, brevisin (ID #23) was identified from *K. brevis* cells [72,96]. Its structure consists of two separate fused polyether ring assemblies linked by a methylene group. One of the polycyclic moieties was conjugated with an aldehyde side chain (Figure 6). Brevisin inhibits the binding of [³H]-BTX-3 on sodium channels in rat brain synaptosomes. In 2011, the total synthesis of brevisin was accomplished [97]. To date, studies regarding this secondary metabolite are limited and further investigation is required.

<figure><img src="image_11.png" /><figcaption>**Figure 6.** Chemical structure of brevisin (ID #23).</figcaption></figure>

## 2.6. Tamulamides

Tamulamides, cyclic polyethers with a ladder-like chemical structure, were isolated from *K. brevis* cultures [73]. Both are composed of seven cyclic ethers with an amide and aldehyde side chain (Figure 7). The molecular formulae of Tamulamide-A (Tam-A; ID #24) and Tamulamide-B (Tam-B; ID #25) are C₃₅H₄₅NO₁₀ and C₃₄H₄₃NO₁₀, respectively (Table 1). Tam-A and Tam-B compete with [³H]-BTX-3 for its binding site on rat brain synaptosomes. Neither showed toxicity to fish at doses up to 200 nM and cause only slight bronchoconstriction in sheep pulmonary assays [73].
<figure><img src="image_12.png" /><figcaption>**Figure 7.** Chemical structures of tamulamide-A (ID #24) and tamulamide-B (ID #25).</figcaption></figure>

## 2.7. Gymnocins

Gymnocins are polyethers biosynthesized by *K. mikimotoi*. Gymnocin-A (ID #26) was the first analog discovered from Japanese cultures of this dinoflagellate, isolated at KUSHI-moto Bay [56] (Figure 1). Structure elucidation revealed 14 saturated ether rings, bearing a 2-methyl-2-butenal side chain (Figure 8). In 2003, this analog was fully synthetized by Tsukano and Sasaki [98]. Gymnocin-A carboxylic acid (ID #27), Gymnocin-A2 (ID #28), Gymnocin-B (ID #29; composed of 15 adjacent rings ending with the same 2-methyl-2-butenal side chain as gymnocin-A) were isolated and elucidated from *K. mikimotoi* [57,58] (Table 1). Conventional fish assays showed that Gymnocin-A and Gymnocin-B are weakly toxic compared to BTX-B [56,57]. However, the authors highlighted that fish were directly exposed to dissolved gymnocins, whereas during red tide events, *K. mikimotoi* cells stuffed the fish gills, allowing direct contact of the gymnocins with the gills. The extremely low solubility of gymnocins to water could prevent them from reaching the fish gills during assays. This mechanism could be involved in the fish mortalities observed in the field, whereas conventional fish assays do not reveal significant toxicity. Gymnocin-A carboxylic acid and Gymnocin-A2 showed moderate cytotoxicity against P388 cells [58].

<figure><img src="image_13.png" /><figcaption>**Figure 8.** Chemical structures of gymnocins.</figcaption></figure>
## 2.8. Gymnodimines (GYMs)

Initially, gymnodimine-A (GYM-A; ID #30) was isolated from extracts of New Zealand oysters (*Tiostrea chilensis*) [24] (Figure 1). Isolation of the active substance made it possible to determine its molecular formula as C₃₂H₄₅NO₄ (Table 1), whereas its absolute stereochemistry was later determined by X-ray crystallography (Figure 9) [99]. The origin of this toxin was first attributed to the dinoflagellate *K. selliformis* for two reasons: efflorescence of the latter was observed at the same time; gymnodimine was isolated in cultures of this species [100]. Two other analogs are known to be produced by *K. selliformis*: GYM-B (ID #31) and GYM-C (ID #32); whereas several others (12-methyl-GYM-A, 12-methyl-GYM-B, GYM-D, 16-desmethyl-GYM-D, GYM-E and more than 30 related gymnodimine-like compounds) have only been identified from *Alexandrium ostenfeldii* or *Alexandrium pe-ruvianum* [59,87,101–104]. The structure of GYM-B is similar to GYM-A, but contains an exocyclic methylene at position C17 and an allylic hydroxyl group at position C18 (Figure 9). GYM-C is an oxidized isomer of GYM-B at position C-18. In 2015, it was demon-strated that GYM-A, GYM-B, and GYM-C could also be produced by *A. ostenfeldii* [105] (Table 1). The use of phytoplankton net sampling allowed for the identification of GYM-A in Australia (Figure 1), together with *K. selliformis* cells (Moreton Bay, Queensland), and in China (Daya Bay) [45,46]. In terms of toxicity, GYM-A demonstrated high intraperitoneal toxicity in mice (LD₅₀ of 80–96 µg kg⁻¹), while very low toxicity was reported after oral exposure [106,107]. Moreover, human toxicity is debatable, since no human poisoning could be associated with this toxin.

<figure><img src="image_14.png" /><figcaption>**Figure 9.** Chemical structures of gymnodimines (GYMs) identified from cultures of *Karenia selliformis*.</figcaption></figure>

## 2.9. Brevisulcenals and Brevisulcatic Acids

The toxin complex produced by *K. brevisulcata* was initially designated as Wellington Harbour Toxin (WHT), after the appearance of a bloom in 1998, which devastated all marine life in this New Zealand harbour [108]. This complex is composed of two groups of toxins: brevisulcenals (KBTs for *K. brevisulcata* toxins) and brevisulcatic acids (BSXs) (Figure 10). KBTs are lipophilic polycyclic ethers with a ladder-like structure [109]. Ten analogs are reported (Table 1); however, only six of them have been well characterized to date: KBT-A1 (ID #33), KBT-A2 (ID #34), KBT-F (ID #35), KBT-G (ID #36), KBT-H (ID #37), and KBT-I (ID #38) [75,76,78,82,110] (Figure 10). The mouse i.p. LD₅₀ for KBT-F and -G are 0.032 and 0.040 mg/kg bw, respectively. KBT-F and KBT-G are strongly haemolytic, cytotoxic to P388 and neuro-2a cells and highly toxic *i.p.* to mice [82]. Brevisulcatic acids are composed of seven analogs with a common nine cyclic ether backbone. BSX-1 (ID #39), BSX-2 (ID #40), BSX-4 (ID #42) and BSX-5 (ID #43) have known structures and are close to those of BTX-A, especially the ladder arrangement [77,79]. BSX-2, -5, and -7 (ID #45) carry a lactone function. Different side chain substituents make up the various BSX analogs [80]. BSX-3 (ID #41) and BSX-6 (ID #44) were isolated from *K. brevisulcata* cultures by means of ¹³C labelled extracts, combined with the use of liquid chromatography with mass spectrometry detection (LC-MS) acquisitions [77]. Their [M + H]⁺ m/z are 857.5
and 839.5, respectively. However, their molecular formula and chemical structure remain unknown. Harwood et al. [110] suggest that BSX-6 could be an important intermediate in BSX biosynthesis. The mouse *i.p.* LD₅₀ for BSX-1 is 3.9 mg/kg, while no deaths were seen in mice injected with BSX-2 at 6.6 mg/kg. The LD₅₀ for the lactones BSX-4 and BSX-5 are 1.4 and 1.6 mg/kg, respectively. BSX-4 and -5 are agonists of voltage-gated sodium channels but only weakly haemolytic. Activities in the Neuro-2a cytotoxicity assay were ca 10% of dihydro-brevetoxin-2 and were fully antagonised by saxitoxin [82].

## Brevisulcenals (KBTs)

<figure><img src="image_15.png" /></figure>

<table><thead><tr><th>Brevisulcenal analog</th><th>Compound ID</th><th>R1</th><th>R2</th><th>R3</th><th>R4</th><th>R5</th><th>R6</th></tr></thead><tbody><tr><td>Brevisulcenal-A1 (KBT-A1)</td><td>#33</td><td>CH<sub>3</sub></td><td>H</td><td>H</td><td>OH</td><td>H</td><td>OSO<sub>3</sub>Na</td></tr><tr><td>Brevisulcenal-A2 (KBT-A2)</td><td>#34</td><td>CH<sub>3</sub></td><td>CH<sub>3</sub></td><td>OH</td><td>H</td><td>OH</td><td>OSO<sub>3</sub>Na</td></tr><tr><td>Brevisulcenal-F (KBT-F)</td><td>#35</td><td>CH<sub>3</sub></td><td>H</td><td>H</td><td>OH</td><td>H</td><td>OH</td></tr><tr><td>Brevisulcenal-G (KBT-G)</td><td>#36</td><td>CH<sub>3</sub></td><td>CH<sub>3</sub></td><td>OH</td><td>H</td><td>OH</td><td>OH</td></tr><tr><td>Brevisulcenal-H (KBT-H)</td><td>#37</td><td>CH<sub>2</sub>OH</td><td>H</td><td>H</td><td>OH</td><td>H</td><td>OH</td></tr><tr><td>Brevisulcenal-I (KBT-I)</td><td>#38</td><td>CH<sub>2</sub>OH</td><td>CH<sub>3</sub></td><td>OH</td><td>H</td><td>OH</td><td>OH</td></tr></tbody></table>

## Brevisulcatic acids (BSXs)

<figure><img src="image_16.png" /><figcaption>**Figure 10.** Chemical structures of brevisulcenals (KBTs) and brevisulcatic acids (BSXs).</figcaption></figure>
**3. Biotransformation of Metabolites Produced by *Karenia* spp. in Shellfish**

This section will only focus on the metabolism of BTXs and GYMs in shellfish. For both, individual analogs have been reported worldwide (Figure 1), whereas data are lacking for the other groups of metabolites produced by *Karenia* spp. [10,20–27,30–33,35–47].

**3.1. Brevetoxins**

**3.1.1. Brevetoxins Already Reported from *Karenia* spp.**

Several BTXs known to be produced by *Karenia* spp. have also been identified in shellfish (Table 2). Whereas BTX-1 (ID #1) has not been found in shellfish, BTX-2 (ID #8) has occasionally been identified in different species [28–31]. In fact, both toxins are extensively metabolized, and several metabolic pathways were proposed [31,32]. A study in which eastern oysters (*Crassostrea virginica*) were exposed under controlled conditions to pure BTX-2 revealed that BTX-2 rapidly accumulated and was metabolized into several compounds, including BTX-3 (ID #9), as a reduced form of BTX-2 [28]. Oysters exposed to BTX-3 toxin showed rapid accumulation and significant elimination (about 90%), without any apparent biotransformation, in two weeks. Among the metabolites reported from *K. brevis*, several oxidized, reduced and A-ring lactone hydrolyzed metabolites of BTX-1 and BTX-2 have also been identified in different shellfish species [20,21,30–34]. It is worth noting that the profile of BTX metabolites and their concentrations varied considerably between bivalve mollusk species. For A-type BTXs, oxidized-BTX-1 (ID #4), open A-ring oxidized BTX-1 (ID #6) and open A-ring BTX-7 (ID #7) were reported in hard clams (*mercenaria sp.*) and eastern oysters (*Crassostrea virginica*). For B-type BTXs, BTX-3, BTX-9 (ID #12), and BTX-B5 (ID #13) have been identified in clams (*Mercenaria sp.*, *Macrocallista nimbosa*), cockles (*Austrovenus stutchburyi*), gastropods (*Triplofusus giganteus*, *Sinistrofulgur sinistrum*, *Cinctura hunteria*, *Strombus alatus*, *Fulguropsis spirata*), mussels (*Perna canaliculus*) and oysters (*Crassostrea gigas*, *Crassostrea virginica*). BTX-3 was reported at higher level than BTX-2 in shellfish, i.e., in oysters (*Crassostrea gigas*) and cockles (*Austrovenus Stutchburyi*) in New Zealand [20,31,33], horse conch (*Triplofusus giganteus*), lightning whelk (*Sinistrofulgur sinistrum*), banded tulip (*Cinctura hunteria*), fighting conch (*Strombus alatus*), pear whelk (*Fulguropsis spirata*), clam (*Mercenaria spp.*) and oyster (*Crassostrea virginica*) in Florida [17,22,111]. BTX-3 and BTX-9 are largely eliminated in oysters after two weeks of depuration [34]. Importantly, open A-ring BTX-1 (ID #5), open A-ring BTX-2 (ID #14), and open A-ring BTX-3 (ID #16), reported from *K. brevis* environmental samples, were not detected. Their extensive metabolism, due to the reactive α,β-unsaturated aldehyde group in their tail region, could explain their absence [35].
<table><caption>**Table 2.** Physicochemical characteristics of brevetoxin (BTX) metabolites reported in marine organisms.</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td rowspan="10">A-type BTXs</td><td>#4</td><td>Oxidized BTX-1</td><td>Oxidized PbTx-1; PbTx-1-carboxylic acid</td><td>C<sub>49</sub>H<sub>70</sub>O<sub>14</sub></td><td>882.5</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#6</td><td>Open A-ring, oxidized BTX-1</td><td>Open A-ring of oxidized PbTx-1; A-type opened A-ring derivative</td><td>C<sub>49</sub>H<sub>72</sub>O<sub>15</sub></td><td>900.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,35]</td></tr><tr><td>#7</td><td>Open A-ring BTX-7</td><td>Open A-ring PbTx-7</td><td>C<sub>49</sub>H<sub>74</sub>O<sub>14</sub></td><td>886.5</td><td>/</td><td>Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Spot (Leiostomus xanthurus)</td><td>[35,39,48]</td></tr><tr><td>#52</td><td>Taurine-BTX-A</td><td>N-taurine conjugate of oxidized BTX-1</td><td>C<sub>51</sub>H<sub>75</sub>NO<sub>16</sub>S</td><td>989.5</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#53</td><td>Cysteine-BTX-A</td><td>Cysteine-PbTx-A; Cysteine-PbTx-1; Cysteine-BTX-1</td><td>C<sub>52</sub>H<sub>79</sub>NO<sub>15</sub>S</td><td>989.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Spot (Leiostomus xanthurus)</td><td>[23,35,39,48]</td></tr><tr><td>#54</td><td>Cysteine-BTX-A sulfoxide</td><td>Cysteine-PbTx-A sulfoxide; Sulfoxide cysteine conjugate of PbTx-1</td><td>C<sub>52</sub>H<sub>79</sub>NO<sub>16</sub>S</td><td>1005.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Spot (Leiostomus xanthurus)</td><td>[23,35,39,48]</td></tr><tr><td>#55</td><td>Open A-ring cysteine-BTX-A</td><td>Open A-ring cysteine-PbTx-A</td><td>C<sub>52</sub>H<sub>81</sub>NO<sub>16</sub>S</td><td>1007.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,34,35,39]</td></tr><tr><td>#56</td><td>Glutathione-BTX-A</td><td>Glutathione-PbTx-A</td><td>C<sub>59</sub>H<sub>89</sub>N<sub>3</sub>O<sub>19</sub>S</td><td>1175.6</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[23,34,39]</td></tr><tr><td>#57</td><td>Glycine-cysteine-BTX-A</td><td>Glycine-cysteine-PbTx-A</td><td>C<sub>54</sub>H<sub>82</sub>N<sub>2</sub>O<sub>16</sub>S</td><td>1046.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[23,39]</td></tr><tr><td>#58</td><td>N-hexadecanoyl-cysteine-BTX-A</td><td>N-hexadecanoyl-cysteine-PbTx-A</td><td>C<sub>68</sub>H<sub>109</sub>NO<sub>16</sub>S</td><td>1227.7</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td>#59</td><td>Metabolite not named</td><td>/</td><td>C<sub>51</sub>H<sub>76</sub>O<sub>16</sub>S</td><td>976.5</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td>#8</td><td>BTX-2</td><td>PbTx-2; T47; GB-2; T34; BTX-B</td><td>C<sub>50</sub>H<sub>70</sub>O<sub>14</sub></td><td>894.5</td><td>6.2</td><td>Cockles (Austrovenus stutchburyi); Mussels (Perna canaliculus); Oysters (Crassostrea virginica, Crassostrea gigas); Sharks (Rhizoprionodon terraenovae, Sphyrna tiburo); Shrimps (Litopenaeus vannamei)</td><td>[10,21,30–32,49,64,112]</td></tr></tbody></table>
<table><caption>Table 2. *Cont.*</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td></td><td>#9</td><td>BTX-3</td><td>PbTx-3; GB-3; T17; dihydro-BTX-B; aldehyde-reduced PbTx-2</td><td>C<sub>50</sub>H<sub>72</sub>O<sub>14</sub></td><td>896.5</td><td>6.4</td><td>Bottlenose dolphins (Tursiops Truncatus); Clams (Mercenaria sp.); Cockles (Austrovenus stutchburyi); Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Mussels (Perna canaliculus); Oysters (Crassostrea gigas, Crassostrea virginica); Pinfish (Lagodon rhomboides); Rays (Dasyatis sabina); Sharks (Carcharhinus limbatus, Rhizoprionodon terraenovae, Sphyrna tiburo); Spot (Leiostomus xanthurus)</td><td>[10,17,20–22,31–33,48–50,66]</td></tr><tr><td></td><td>#16</td><td>Open A-ring BTX-3</td><td>Open-ring PbTx-3</td><td>C<sub>50</sub>H<sub>74</sub>O<sub>15</sub></td><td>914.5</td><td>/</td><td>Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Spot (Leiostomus xanthurus)</td><td>[17,35,48]</td></tr><tr><td></td><td>#12</td><td>BTX-9</td><td>Reduced-BTX-2</td><td>C<sub>50</sub>H<sub>74</sub>O<sub>14</sub></td><td>898.5</td><td>6.3</td><td>Oysters (Crassostrea virginica)</td><td>[34,39]</td></tr><tr><td></td><td>#13</td><td>BTX-B5</td><td>Oxidized BTX-2; Oxidized PbTx-2; PbTx-2-carboxylic acid</td><td>C<sub>50</sub>H<sub>70</sub>O<sub>15</sub></td><td>910.5</td><td>6.7</td><td>Clams (Mercenaria sp., Macrocallista nimbosa); Cockles (Austrovenus stutchburyi); Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Mussels (Perna canaliculus); Oysters (Crassostrea gigas, Crassostrea virginica)</td><td>[17,22,23,31–33,39]</td></tr><tr><td></td><td>#15</td><td>Open A-ring, oxidized BTX-2</td><td>Open ring, oxidized PbTx-2; Open A-ring BTX-B5; PbTx-2-open ring-carboxylic acid</td><td>C<sub>50</sub>H<sub>72</sub>O<sub>16</sub></td><td>928.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,23,35]</td></tr></tbody></table>
<table><caption>**Table 2. Cont.**</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td></td><td>#60</td><td>Oxidized, open D-ring tetradecanoyl-BTX-2</td><td>BTX-B3; Oxidized, open D-ring myristoyl-BTX-2</td><td>C<sub>64</sub>H<sub>96</sub>O<sub>17</sub></td><td>1136.7</td><td>/</td><td>Mussels (Perna canaliculus)</td><td>[36]</td></tr><tr><td></td><td>#61</td><td>Oxidized, open D-ring hexadecanoyl-BTX-2</td><td>BTX-B3; Oxidized, open D-ring palmitoyl-BTX-2</td><td>C<sub>66</sub>H<sub>100</sub>O<sub>17</sub></td><td>1164.7</td><td>/</td><td>Mussels (Perna canaliculus)</td><td>[36]</td></tr><tr><td></td><td>#62</td><td>Taurine-BTX-B</td><td>BTX-B1; N-taurine conjugate of oxidized PbTx-2; N-taurine conjugate of BTX-B5</td><td>C<sub>52</sub>H<sub>75</sub>NO<sub>17</sub>S<sup>2</sup></td><td>1017.5<sup>2</sup></td><td>/</td><td>Clams (Mercenaria sp.; Macrocallista nimbosa); Cockles (Austrovenus stutchburyi); Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Mussels (Perna canaliculus); Oysters (Crassostrea gigas)</td><td>[17,20,22,23,31–33,37]</td></tr><tr><td></td><td>#63</td><td>Cysteine-BTX-B</td><td>S-desoxy-BTX-B2; S-deoxy-BTX-B2; Cysteine-BTX-B; Cysteine-PbTx; Cysteine-PbTx-B; Cysteine conjugate of PbTx-2</td><td>C<sub>53</sub>H<sub>79</sub>NO<sub>16</sub>S</td><td>1017.5</td><td>/</td><td>Clams (Mercenaria sp.; Macrocallista nimbosa); Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Sharks (Carcharhinus limbatus, Rhizoprionodon terraenovae, Sphyrna tiburo); Spot (Leiostomus xanthurus); Rays (Dasyatis sabina)</td><td>[17,22,23,28,34,35,48,49]</td></tr></tbody></table>
<table><caption>Table 2. *Cont.*</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td></td><td>#64</td><td>Cysteine-BTX-B sulfoxide</td><td>BTX-B2; Cysteine-PbTx-B sulfoxide; Cysteine-PbTx sulfoxide; Oxidised-S-desoxy-BTX-B2</td><td>C<sub>53</sub>H<sub>79</sub>NO<sub>17</sub>S</td><td>1033.5</td><td>4.3</td><td>Clams (Mercenaria sp., Macrocallista nimbosa); Gastropods (Triplofusus giganteus, Sinistrofulgur sinistrum, Cinctura hunteria, Strombus alatus, Fulguropsis spirata); Mussels (Perna canaliculus); Oysters (Crassostrea virginica); Pinfish (Lagodon rhomboides); Sharks (Carcharhinus limbatus, Rhizoprionodon terraenovae, Sphyrna tiburo); Spot (Leiostomus xanthurus); Rays (Dasyatis sabina)</td><td>[17,22,23,28,34,35,38,48,49]</td></tr><tr><td></td><td>#65</td><td>Oxidized cysteine-BTX-2</td><td>Cysteine conjugate of oxidized PbTx-2</td><td>C<sub>53</sub>H<sub>77</sub>NO<sub>17</sub>S</td><td>1031.5</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td></td><td>#66</td><td>Open A-ring cysteine-BTX-B</td><td>Open A-ring S-desoxy-BTX-B2; Open A-ring cysteine-PbTx-B; Open A-ring cysteine-PbTx-2</td><td>C<sub>53</sub>H<sub>81</sub>NO<sub>17</sub>S</td><td>1035.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,34,35,39]</td></tr><tr><td></td><td>#67</td><td>Glycine-cysteine-BTX-B</td><td>Glycine-cysteine-PbTx-B</td><td>C<sub>55</sub>H<sub>82</sub>N<sub>2</sub>O<sub>17</sub>S</td><td>1074.5</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,34,39]</td></tr><tr><td></td><td>#68</td><td>γ-glutamyl-cysteine-BTX-B</td><td>γ-glutamyl-cysteine-PbTx-B</td><td>C<sub>58</sub>H<sub>86</sub>N<sub>2</sub>O<sub>19</sub>S</td><td>1146.6</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,34,39]</td></tr><tr><td></td><td>#69</td><td>Glutathione-BTX-B</td><td>Glutathione-PbTx-B</td><td>C<sub>60</sub>H<sub>89</sub>N<sub>3</sub>O<sub>20</sub>S</td><td>1203.6</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,34,39]</td></tr><tr><td></td><td>#70</td><td>N-tetradecanoyl-cysteine-BTX-B sulfoxide</td><td>BTX-B4; N-tetradecanoyl-BTX-B2; N-myristoyl-BTX-B2; N-myristoyl-cysteine-PbTx-B sulfoxide</td><td>C<sub>67</sub>H<sub>105</sub>NO<sub>18</sub>S</td><td>1243.7</td><td>11.3</td><td>Mussels (Perna canaliculus); Oysters (Crassostrea virginica)</td><td>[39,40]</td></tr><tr><td></td><td>#71</td><td>N-hexadecanoyl-cysteine-BTX-B sulfoxide</td><td>BTX-B4; N-hexadecanoyl-BTX-B2; N-palmitoyl-BTX-B2; N-hexadecanoyl-cysteine-PbTx-B sulfoxide</td><td>C<sub>69</sub>H<sub>109</sub>NO<sub>18</sub>S</td><td>1271.7</td><td>12.3</td><td>Clams (mercenaria sp.); Mussels (Perna canaliculus); Oysters (Crassostrea virginica)</td><td>[22,34,39]</td></tr></tbody></table>
<table><caption>Table 2. *Cont.*</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td>#72</td><td></td><td>N-(hydroxy-hexadecenoyl)-cysteine-BTX-B sulfoxide</td><td>N-(hydroxy-hexadecenoyl)-BTX-B2</td><td>C<sub>69</sub>H<sub>107</sub>NO<sub>19</sub>S</td><td>1285.7</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#73</td><td></td><td>N-octadecanoyl-cysteine-BTX-B sulfoxide</td><td>N-octadecanoyl-BTX-B2</td><td>C<sub>71</sub>H<sub>113</sub>NO<sub>18</sub>S</td><td>1299.8</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#74</td><td></td><td>N-octadecenoyl-cysteine-BTX-B sulfoxide</td><td>N-octadecenoyl-BTX-B2</td><td>C<sub>71</sub>H<sub>111</sub>NO<sub>18</sub>S</td><td>1297.8</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#75</td><td></td><td>N-(hydroxy-eicosanoyl)-cysteine-BTX-B sulfoxide</td><td>N-(hydroxy-eicosanoyl)-BTX-B2</td><td>C<sub>73</sub>H<sub>117</sub>NO<sub>19</sub>S</td><td>1343.8</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#76</td><td></td><td>N-arachidonyl-cysteine-BTX-B sulfoxide</td><td>N-arachidonyl-BTX-B2</td><td>C<sub>73</sub>H<sub>109</sub>NO<sub>18</sub>S</td><td>1319.7</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#77</td><td></td><td>N-didecenoyl-cysteine-BTX-B sulfoxide</td><td>N-didecenoyl-BTX-B2</td><td>C<sub>73</sub>H<sub>115</sub>NO<sub>18</sub>S</td><td>1325.8</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#78</td><td></td><td>N-tetradecanoyl-cysteine-BTX-B</td><td>N-tetradecanoyl-cysteine-PbTx-B</td><td>C<sub>67</sub>H<sub>105</sub>NO<sub>18</sub>S</td><td>1243.7</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td>#79</td><td></td><td>N-hexadecanoyl-cysteine-BTX-B</td><td>N-hexadecanoyl-cysteine-PbTx-B; N-hexadecanoyl-S-deoxy-BTX-B2</td><td>C<sub>69</sub>H<sub>109</sub>NO<sub>17</sub>S</td><td>1255.7</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,39]</td></tr><tr><td>#80</td><td></td><td>N-(hydroxy-hexadecenoyl)-cysteine-BTX-B</td><td>N-(hydroxy-hexadecenoyl)-S-deoxy-BTX-B2</td><td>C<sub>69</sub>H<sub>107</sub>NO<sub>18</sub>S</td><td>1269.7</td><td>/</td><td>Clams (mercenaria sp.)</td><td>[22]</td></tr><tr><td>#81</td><td></td><td>N-octadecanoyl-cysteine-BTX-B</td><td>N-octadecanoyl-cysteine-PbTx-B; N-octadecanoyl-S-deoxy-BTX-B2</td><td>C<sub>71</sub>H<sub>113</sub>NO<sub>17</sub>S</td><td>1283.8</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,39]</td></tr><tr><td>#82</td><td></td><td>N-octadecenoyl-cysteine-BTX-B</td><td>N-octadecenoyl-cysteine-PbTx-B</td><td>C<sub>71</sub>H<sub>111</sub>NO<sub>17</sub>S</td><td>1281.8</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td>#83</td><td></td><td>N-eicosenoyl-cysteine-BTX-B</td><td>N-eicosenoyl-cysteine-PbTx-B</td><td>C<sub>73</sub>H<sub>115</sub>NO<sub>17</sub>S</td><td>1309.8</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr></tbody></table>
<table><caption>**Table 2. Cont.**</caption><thead><tr><th>Group</th><th>Compound Identification Number (ID)</th><th>Metabolite</th><th>Other Existing Names</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP<sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td></td><td>#84</td><td>N-(hydroxy-eicosanoyl)-cysteine-BTX-B</td><td>N-(hydroxy-eicosanoyl)-cysteine-PbTx-B; N-(hydroxy-eicosanoyl)-S-deoxy-BTX-B2</td><td>C<sub>73</sub>H<sub>117</sub>NO<sub>18</sub>S</td><td>1327.8</td><td>/</td><td>Clams (mercenaria sp.); Oysters (Crassostrea virginica)</td><td>[22,39]</td></tr><tr><td></td><td>#85</td><td>Glycine-(N-tetradecanoyl)-cysteine-BTX-B</td><td>Glycine-(N-tetradecanoyl-cysteine)-PbTx-B</td><td>C<sub>69</sub>H<sub>108</sub>N<sub>2</sub>O<sub>18</sub>S</td><td>1284.7</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td></td><td>#86</td><td>Glycine-(N-hexadecanoyl)-cysteine-BTX-B</td><td>Glycine-(N-hexadecanoyl-cysteine)-PbTx-B</td><td>C<sub>71</sub>H<sub>112</sub>N<sub>2</sub>O<sub>18</sub>S</td><td>1312.8</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td></td><td>#87</td><td>Glycine-(N-hydroxy-eicosanoyl)-cysteine-BTX-B</td><td>Glycine-(N-hydroxy-eicosanoyl)-cysteine-PbTx-B</td><td>C<sub>75</sub>H<sub>120</sub>N<sub>2</sub>O<sub>19</sub>S</td><td>1384.8</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[39]</td></tr><tr><td></td><td>#88</td><td>Metabolite not named</td><td>/</td><td>C<sub>52</sub>H<sub>76</sub>O<sub>17</sub>S</td><td>1004.5</td><td>/</td><td>Oysters (Crassostrea virginica)</td><td>[30,39]</td></tr></tbody></table>

<footnote n="1">¹ LogP predicted from the chemical structure of molecules using the ACD/Labs platform. Octanol/water partition coefficient are predicted using algorithms. ² Sometimes refers to the sodium salt of taurine-BTX-B with a molecular formula of C₅₂H₇₄NO₁₇SNa and a monoisotopic mass of 1039.5 Da [20,37].</footnote>
### 3.1.2. Fatty Acid Conjugates of Brevetoxins

BTX-B3 is not a single compound, but a mixture of two fatty acid conjugates (myristic and palmitic acids) of the open D-ring of BTX-2 with oxidation of the terminal aldehyde (ID #60 and #61) (Figure 11) [36]. Therefore, the use of the term BTX-B3 is discouraged from a chemical perspective (Table 2). These analogs were isolated from greenshell mussels (*Perna canaliculus*) involved in the NSP events of 1992–1993. Interestingly, the mixture of these fatty acid conjugates did not kill mice by intraperitoneal injection at a dose of 300 µg/kg [36]. No further fatty acid conjugates of BTXs (without amino-acid conjugation) were reported.

<figure><img src="image_17.png" /></figure>

<table><caption>**Figure 11.** Chemical structures of fatty acid conjugates of brevetoxins (BTXs).</caption><thead><tr><td>Fatty acid conjugates of brevetoxins</td><td>Compound ID</td><td>R</td></tr></thead><tbody><tr><td>Oxidized, open D-ring tetradecanoyl-BTX-2</td><td>#60</td><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>12</sub>CO</td></tr><tr><td>Oxidized, open D-ring hexadecanoyl-BTX-2</td><td>#61</td><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>14</sub>CO</td></tr></tbody></table>

### 3.1.3. Amino Acid/Peptide Conjugates of Brevetoxins

As previously described, taurine-BTX-B (ID #62; also called BTX-B1) and cysteine-BTX-B sulfoxide (ID #64; also called BTX-B2) were the first amino acid conjugates of BTXs identified [37,38], quickly followed by a series of amino acid/peptide conjugates (cysteine, taurine, glycine-cysteine, glutathione, γ-glutamyl-cysteine), among which figure the open A-ring conjugates [22,23,28,34,35,39,48]. Their structures are presented in Figure 12 (ID #52, #53, #54, #55, #56, #57, #62, #63, #64, #65, #66, #67, #68 and #69). Studies from oysters (*Crassostrea virginica*) exposed to *K. brevis* cultures demonstrated the accumulation of several metabolic products like cysteine-BTX-A (ID #53), cysteine-BTX-B (ID #63) and their respective sulfoxides (ID #54 and #64), which were then slowly eliminated [28,34,39]. These metabolites were detectable for up to 6 months in oysters. Additionally, cysteine-BTX-B sulfoxide could also be formed during shellfish extraction or storage of the extracts after sulfoxidation of cysteine-BTX-B [4]. It is important to consider this point to better estimate the actual metabolite content in shellfish in the field. A few years later, after repeated *K. brevis* blooms over a 3-year period in Sarasota Bay (Florida, USA), cysteine-BTX-B and its sulfoxide conjugate were detected in oysters (*Crassostrea virginica*) and were the most abundant and persistent metabolites among those monitored (BTX-3, cysteine and cysteine sulfoxide conjugates of BTX-A and BTX-B) [113]. Six months after experimental exposure to *K. brevis*, both conjugates were still detectable in tissues. The following peptide conjugates were later discovered with BTX-A and BTX-B backbone structures: glycine-cysteine-BTX (m/z 1047 and 1075, with respective ID numbers of #57 and #67), γ-glutamyl-cysteine-BTX (m/z 1147; ID #86), and glutathione-BTX (m/z 1176 and 1204, with respective ID numbers of #56 and #69) [39]. As for BTXs directly produced from *K. brevis*, the lactone group in the A-ring of the conjugate metabolites may open under certain conditions through hydrolysis. Cysteine-BTX-A and cysteine-BTX-B have been identified with their lactone ring opened (ID #55 and #66, respectively) in oysters (*Crassostrea virginica*) [34,35,39]. Binding these amino acids or peptides on the algal toxins decreases lipophilicity and can require method adjustments. The presence of more polar metabolites than algal BTXs has been demonstrated in oysters (*Crassostrea virginica*) that were naturally and experimentally exposed to *K. brevis* [35].
Brevetoxin-A backbone

<figure><img src="image_18.png" /></figure>

Brevetoxin-B backbone

<figure><img src="image_19.png" /><figcaption>**Figure 12.** Chemical structures of the amino acid/peptide metabolites of brevetoxins (BTXs) identified from shellfish.</figcaption></figure>
### 3.1.4. Fatty Acid Derivatives of Brevetoxin Amino acid Conjugates

In most cases, fatty acids react with amino acid–BTX conjugates (or peptide-BTX conjugates) through amide linkage to form a series of 19 fatty acid–amino acid–BTX conjugates (ID #58 and #70 to #87 presented in Figure 13). A greater number of amino acid–fatty acid conjugates of BTX-B have been identified compared to BTX-A. BTX-B4, the first isolated, is a mixture of N-tetradecanoyl (N-myristoyl) and N-hexadecanoyl (N-palmitoyl) conjugates with the cysteine sulfoxide moiety of BTX-B2 (ID #70 and #71, respectively) [36,40]. Therefore, as for BTX-B3 (ID #60 and #61), the use of the term BTX-B4 is discouraged. Based on MS/MS fragmentations, Wang et al. [39] reported numerous new analogs, all mentioned in Table 2. Several of these metabolites were confirmed in hard clams (*Mercenaria sp.*) naturally exposed to *K. brevis* blooms [22].

### 3.1.5. Other Brevetoxin Metabolites

Two metabolites, with m/z of 976.5 and 1004.5 (ID #59 and #88, respectively), have been identified from Eastern oysters (*Crassostrea virginica*) collected in the Gulf of Mexico [30,39]. These compounds have not been named. LC-MS/MS analysis revealed the presence of characteristic fragments of A-type and B-type backbone structure of BTXs, allowing Wang et al. [39] to propose structures and fragmentation pathways (Figure 14). In both cases, the side chain possesses sulfoxide and carboxylic acid functions. These metabolites were much more abundant in field-exposed oysters compared with laboratory-exposed oysters. Since 2004, these BTX metabolites have never been reported in the literature.

### 3.1.6. Biomarkers of Brevetoxin Exposure in Shellfish

The great diversity of physicochemical properties of BTXs complicates the development of efficient multi-toxin analytical methods. Importantly, the products of shellfish metabolism have different lipophilic properties compared to their precursor. The binding of an amino acid or a peptide to the algal toxin contributes to decreased lipophilicity, while binding of a fatty acid increases it. Therefore, the extraction of metabolites with highly variable polarities constitutes a major difficulty. For this reason, different authors emphasized the relevance of use several metabolites as biomarkers of BTX exposure to monitor the toxicity of shellfish following a *K. brevis* bloom [4,18,23]. BTX-3 (ID #9), BTX-B5 (ID #13), taurine-BTX-B (BTX-B1; ID #62), cysteine-BTX-B (S-deoxy-BTX-B2, ID #63), and cysteine-BTX-B sulfoxide (BTX-B2, ID #64) constitute relevant candidates due to their relative persistence. Nevertheless, considering the toxin profile differences between shellfish species, the appropriate biomarkers should be chosen carefully depending on the monitored shellfish species. This high specificity may also complicate the broad application of biomarkers of exposure when different species are targeted. Recently, a strategy was successfully applied to monitor BTX-B in gastropods (*Triplofusus giganteus*, *Sinistrofulgur sinistrum*, *Cinctura hunteria*, *Strombus alatus*, *Fulguropsis spirata*) and in one species of clams (*Macrocallista nimbosa*) [17]. All gastropod samples were contaminated by BTX-3 (ID #9), BTX-B5 (ID #13), open A-ring BTX-3 (ID #16), taurine-BTX-B (ID #62), cysteine-BTX-B (ID #63) and cysteine-BTX-B sulfoxide (ID #64). Clam samples contained the same metabolites, besides BTX-3 and open A-ring BTX-3.
<figure><img src="image_20.png" /><figcaption>N-hexadecanoyl-cysteine-BTX-A
(ID #58)</figcaption></figure>

<figure><img src="image_21.png" /><figcaption>Amino-acid-fatty acid conjugate
Fatty acid chain</figcaption></figure>

<table><caption>N-fatty acyl-cysteine-BTX-B</caption><thead><tr><th></th><th>Compound ID</th><th>Chain length</th><th>Hydroxyl groups</th><th>R</th></tr></thead><tbody><tr><td>N-tetradecanoyl-cysteine-BTX-B sulfoxide</td><td>#70</td><td>C14:0</td><td>0</td><td>C13H27</td></tr><tr><td>N-hexadecanoyl-cysteine-BTX-B sulfoxide</td><td>#71</td><td>C16:0</td><td>0</td><td>C15H31</td></tr><tr><td>N-(hydroxy-hexadecenoyl)-cysteine-BTX-B sulfoxide</td><td>#72</td><td>C16:1</td><td>1</td><td>C15H29O</td></tr><tr><td>N-octadecanoyl-cysteine-BTX-B sulfoxide</td><td>#73</td><td>C18:0</td><td>0</td><td>C17H33</td></tr><tr><td>N-octadecenoyl-cysteine-BTX-B sulfoxide</td><td>#74</td><td>C18:1</td><td>0</td><td>C17H33</td></tr><tr><td>N-(hydroxy-eicosanoyl)-cysteine-BTX-B sulfoxide</td><td>#75</td><td>C20:0</td><td>1</td><td>C19H39O</td></tr><tr><td>N-arachidonyl-cysteine-BTX-B sulfoxide</td><td>#76</td><td>C20:4</td><td>0</td><td>C19H31</td></tr><tr><td>N-didecenoyl-cysteine-BTX-B sulfoxide</td><td>#77</td><td>C20:1</td><td>0</td><td>C19H37</td></tr></tbody></table>

<figure><img src="image_22.png" /><figcaption>Amino-acid-fatty acid conjugate
Fatty acid chain</figcaption></figure>

<table><caption>Glycine-(N-fatty acyl)-cysteine-BTX-B</caption><thead><tr><th></th><th>Compound ID</th><th>Chain length</th><th>Hydroxyl groups</th><th>R</th></tr></thead><tbody><tr><td>N-tetradecanoyl-cysteine-BTX-B</td><td>#78</td><td>C14:0</td><td>0</td><td>C13H27</td></tr><tr><td>N-hexadecanoyl-cysteine-BTX-B</td><td>#79</td><td>C16:0</td><td>0</td><td>C15H31</td></tr><tr><td>N-(hydroxy-hexadecenoyl)-cysteine-BTX-B</td><td>#80</td><td>C16:1</td><td>1</td><td>C15H29O</td></tr><tr><td>N-octadecanoyl-cysteine-BTX-B</td><td>#81</td><td>C18:0</td><td>0</td><td>C17H35</td></tr><tr><td>N-octadecenoyl-cysteine-BTX-B</td><td>#82</td><td>C18:1</td><td>0</td><td>C17H33</td></tr><tr><td>N-eicosenoyl-cysteine-BTX-B</td><td>#83</td><td>C20:1</td><td>0</td><td>C19H37</td></tr><tr><td>N-(hydroxy-eicosanoyl)-cysteine-BTX-B</td><td>#84</td><td>C20:0</td><td>1</td><td>C19H39O</td></tr></tbody></table>

<figure><img src="image_23.png" /><figcaption>Amino-acid-fatty acid conjugate
Fatty acid chain</figcaption></figure>

<table><caption>**Figure 13.** Chemical structures of amino acid-fatty acid conjugates of brevetoxins (BTXs) metabolized in shellfish.</caption><thead><tr><th></th><th>Compound ID</th><th>Chain length</th><th>Hydroxyl groups</th><th>R</th></tr></thead><tbody><tr><td>Glycine-(N-tetradecanoyl)-cysteine-BTX-B</td><td>#85</td><td>C14:0</td><td>0</td><td>C13H27</td></tr><tr><td>Glycine-(N-hexadecanoyl)-cysteine-BTX-B</td><td>#86</td><td>C16:0</td><td>0</td><td>C15H31</td></tr><tr><td>Glycine-(N-hydroxy-eicosanoyl)-cysteine-BTX-B</td><td>#87</td><td>C20:0</td><td>1</td><td>C19H39O</td></tr></tbody></table>
<figure><img src="image_24.png" /><figcaption>**Figure 14.** Chemical structures of other brevetoxin (BTX) metabolites identified from shellfish.</figcaption></figure>

### 3.1.7. Monitoring Programs for Brevetoxins in Shellfish

In the United States, brevetoxins widely impact the coasts, especially in the Gulf of Mexico. The closure of production areas is based on *Karenia* spp. cell count or toxin analysis in shellfish tissues. A maximum limit of 20 mouse units per 100 g of tissue is applied using the mouse bioassay (MBA) and, with certain limitations, the enzyme linked immunosorbent assay (ELISA), as described in the National Shellfish Sanitation Program [114]. The re-opening of production areas is based on toxin analysis. With these analytical tools, the identity of the analogs remains unknown. In Australia, production area closures have different strategies depending on the federal states. MBA is implemented in Victoria and New South Wales; however, an LC-MS/MS analysis is also carried out in New South Wales [115,116]. BTX-2 (ID #8), BTX-3 (ID #9), BTX-B5 (ID #13), taurine-BTX-B (BTX-B1; ID #62), cysteine-BTX-B (S-desoxy-BTX-B2; ID #63), and cysteine-BTX-B sulfoxide (BTX-B2; ID #64) are the BTX analogs sought [117]. In New Zealand, BTXs are regulated (maximum permissible level of 0.8 mg BTX-2 equivalent per kg of shellfish meat) and the reference method is based on LC-MS [118]. In France, BTX-2 and BTX-3 have been monitored since 2018 [10] as part of a program on emerging toxins in marine shellfish (EMERGTOX). Recently, a working group was set up by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) to prevent health risks associated with the consumption of shellfish contaminated with BTXs [11,119]. A guidance level of 180 µg BTX-3 eq./kg shellfish meat was established, considering a protective default portion size of 400 g shellfish meat. A monitoring strategy has also been proposed and is divided into three parts [119]. First, the implementation of an ELISA test for the screening of B-type brevetoxin metabolites in shellfish flesh. This approach considers brevetoxins not quantifiable by LC-MS/MS due to the lack of commercial standards. Second, the targeted physicochemical analysis of brevetoxins for which standards are available with an LC-MS/MS method developed for a wide range of polarity. Based on available reference materials and toxicity data, a list of analogs to seek first was established and includes: BTX-1 (ID #1), BTX-2 (ID #8), BTX-3 (ID #9), oxidized open D-ring tetradecanoyl-BTX-2 (BTX-B3; ID #60), oxidized open D-ring hexadecanoyl-BTX-2 (BTX-B3; ID #61), taurine-BTX-B (BTX-B1; ID #62), cysteine-BTX-B (S-desoxy-BTX-B2; ID #63), cysteine-BTX-B sulfoxide (BTX-B2; ID #64), N-tetradecanoyl-cysteine-BTX-B sulfoxide (N-myristoyl-BTX-B2; ID #70), and N-hexadecanoyl-cysteine-BTX-B sulfoxide (N-palmitoyl-BTX-B2; ID #71). Lastly, the implementation of a non-targeted analysis using liquid chromatography-high res-
olution mass spectrometry (LC-HRMS) has been suggested to screen a large number of compounds and identify possible new BTX analogs or degradation products.

## 3.2. *Gymnodimines* (GYMs)

Several studies have demonstrated the accumulation of gymnodimines (GYMs) in different shellfish species (Table 3). The discovery of GYM-A (ID #30) from New Zealand oysters (*Tiostrea chilensis*) in 1995 immediately highlighted this capacity [24]. A few years later, several batches of clams harvested in Tunisia were neurotoxic to mice by i.p. [27]. Analytical investigations allowed for the unequivocal identification of GYM-A. Several studies on Tunisian samples followed [25,26]. In 2012, GYM-A, GYM-B (ID #31) and GYM-C (ID #32) were detected in the same shellfish species collected in the Gulf of Gabes, along with the presence of *K. selliformis* [25]. Other studies were carried out in South Africa, Australia, and China (Figure 1) and allowed for the detection of GYM-A in oysters, gastropods, mussels, donax and pen shells [43–47]. In 2013, numerous gymnodimine fatty acid conjugates were identified from grooved carpet shells (*Ruditapes decussatus*) collected in Tunisia (Gulf of Gabes) [42]. In total, 46 fatty acid conjugates of GYM-A (ID #89 to ID #134) have been reported, with acyl carbon chain lengths comprised between C12:0 and C24:6 (Table 3). The presence of a series of GYM-B and GYM-C fatty acid conjugates was also established, with esters of 16, 18, 20 and 22 carbon chain lengths being the most abundant. However, only the 18:0 esters of GYM-B and GYM-C were specifically identified, with respective ID number of #135 and # ID136 (Figure 15). Some of the GYM-A fatty acids conjugates were also identified in shellfish collected in the South China Sea [41]. Clam (*Antigona lamellaris*) and pen shell (*Atrina pectinata*) profiles were different. In clams, the 18:0 ester was the most abundant, followed by the 20:1 ester, whereas the 20:1, 18:0 and 22:2 esters dominated the acyl ester profile in pen shell samples. These authors also experimentally exposed mussels (*Mytilus galloprovincialis*) to *K. selliformis* for 96 h. In all, 28 fatty acids esters were detected with acyl carbon chain lengths ranging between C14:0 and C24:6. Interestingly, GYM-A was detected in oysters (*Crassostrea sp.*) and gastropods (*Batillaria zonalis*), but no GYM-A esters were observed in these species. Further investigations are required to obtain better knowledge of GYM toxicity. However, considering the significant presence of GYM acyl esters, more occurrence data are required to conduct a risk assessment at a later stage.
<table><caption>**Table 3.** Physicochemical characteristics of gymnodimine (GYM) metabolites reported in shellfish (only gymnodimine analogs produced from *K. selliformis*).</caption><thead><tr><th>Gymnodimine (GYM) Metabolite</th><th>Compound Identification Number (ID)</th><th>Carboxyl Group of the Ester (Carbon:Unsaturation)</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td>GYM-A</td><td>#30</td><td>/</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>4</sub></td><td>507.3</td><td>6.4</td><td>Clams (Antigona lamella, Ruditapes decussatus);<br>Gastropods (Batillaria zonalis);<br>Oysters (Crassostrea angulata, Crassostrea ariakensis, Crassostrea gigia, Dendostrea crenulifrea, Saccostrea glomerata, Tiostrea chilensis);<br>Mussels (Choromytilus meridionalis, Mytilus galloprovincialis, Modiolus proclivis);<br>Pipis (Donax deltoides);<br>Pen shells (Atrina pectinata);</td><td>[24-27,41,44-47]</td></tr><tr><td>GYM-B</td><td>#31</td><td>/</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>5</sub></td><td>523.3</td><td>5.1</td><td>Clams (Ruditapes decussatus);<br>Mussels (M. galloprovincialis)</td><td>[25,41,42]</td></tr><tr><td>GYM-C</td><td>#32</td><td>/</td><td>C<sub>32</sub>H<sub>45</sub>NO<sub>5</sub></td><td>523.3</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[25,42]</td></tr><tr><td>10-O-dodecanoyl-GYM-A</td><td>#89</td><td>12:0</td><td>C<sub>44</sub>H<sub>67</sub>NO<sub>5</sub></td><td>689.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-dodecenoyl-GYM-A</td><td>#90</td><td>12:1</td><td>C<sub>44</sub>H<sub>65</sub>NO<sub>5</sub></td><td>687.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-tetradecanoyl GYM-A</td><td>#91</td><td>14:0</td><td>C<sub>46</sub>H<sub>71</sub>NO<sub>5</sub></td><td>717.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-tetradecenoyl GYM-A</td><td>#92</td><td>14:1</td><td>C<sub>46</sub>H<sub>69</sub>NO<sub>5</sub></td><td>715.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-tetradecatrienoyl-GYM-A</td><td>#93</td><td>14:3</td><td>C<sub>46</sub>H<sub>65</sub>NO<sub>5</sub></td><td>711.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-pentadecanoyl-GYM-A</td><td>#94</td><td>15:0</td><td>C<sub>47</sub>H<sub>73</sub>NO<sub>5</sub></td><td>731.5</td><td>/</td><td>Clams (Ruditapes decussatus);<br>Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-pentadecenoyl-GYM-A</td><td>#95</td><td>15:1</td><td>C<sub>47</sub>H<sub>71</sub>NO<sub>5</sub></td><td>729.5</td><td>/</td><td>Clams (Ruditapes decussatus);<br>Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-hexadecanoyl-GYM-A</td><td>#96</td><td>16:0</td><td>C<sub>48</sub>H<sub>75</sub>NO<sub>5</sub></td><td>745.6</td><td>/</td><td>Clams (Ruditapes decussatus, Antigona lamellaris);<br>Pen shell (Atrina pectinata);<br>Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr></tbody></table>
<table><caption>Table 3. *Cont.*</caption><thead><tr><th>Gymnodimine (GYM) Metabolite</th><th>Compound Identification Number (ID)</th><th>Carboxyl Group of the Ester (Carbon:Unsaturation)</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td>10-O-hexadecenoyl-GYM-A</td><td>#97</td><td>16:1</td><td>C<sub>48</sub>H<sub>73</sub>NO<sub>5</sub></td><td>743.5</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-hexadecadienoyl-GYM-A</td><td>#98</td><td>16:2</td><td>C<sub>48</sub>H<sub>71</sub>NO<sub>5</sub></td><td>741.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-hexadecatrienoyl-GYM-A</td><td>#99</td><td>16:3</td><td>C<sub>48</sub>H<sub>69</sub>NO<sub>5</sub></td><td>739.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-hexadecatetraenoyl-GYM-A</td><td>#100</td><td>16:4</td><td>C<sub>48</sub>H<sub>67</sub>NO<sub>5</sub></td><td>737.5</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heptadecanoyl-GYM-A</td><td>#101</td><td>17:0</td><td>C<sub>49</sub>H<sub>77</sub>NO<sub>5</sub></td><td>759.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-heptadecenoyl-GYM-A</td><td>#102</td><td>17:1</td><td>C<sub>49</sub>H<sub>75</sub>NO<sub>5</sub></td><td>757.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-heptadecadienoyl-GYM-A</td><td>#103</td><td>17:2</td><td>C<sub>49</sub>H<sub>73</sub>NO<sub>5</sub></td><td>755.5</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-octadecanoyl-GYM-A</td><td>#104</td><td>18:0</td><td>C<sub>50</sub>H<sub>79</sub>NO<sub>5</sub></td><td>773.6</td><td>/</td><td>Clams (Ruditapes decussatus, Antigona lamellaris); Pen shell (Atrina pectinata); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-octadecenoyl-GYM-A</td><td>#105</td><td>18:1</td><td>C<sub>50</sub>H<sub>77</sub>NO<sub>5</sub></td><td>771.6</td><td>/</td><td>Clams (Ruditapes decussatus; Antigona lamellaris); Pen shell (Atrina pectinata); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-octadecadienoyl-GYM-A</td><td>#106</td><td>18:2</td><td>C<sub>50</sub>H<sub>75</sub>NO<sub>5</sub></td><td>769.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-octadecatrienoyl-GYM-A</td><td>#107</td><td>18:3</td><td>C<sub>50</sub>H<sub>73</sub>NO<sub>5</sub></td><td>767.5</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-octadecatetraenoyl-GYM-A</td><td>#108</td><td>18:4</td><td>C<sub>50</sub>H<sub>71</sub>NO<sub>5</sub></td><td>765.5</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-nonadecanoyl-GYM-A</td><td>#109</td><td>19:0</td><td>C<sub>51</sub>H<sub>81</sub>NO<sub>5</sub></td><td>787.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-nonadecenoyl-GYM-A</td><td>#110</td><td>19:1</td><td>C<sub>51</sub>H<sub>79</sub>NO<sub>5</sub></td><td>785.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr></tbody></table>
<table><caption>Table 3. *Cont.*</caption><thead><tr><th>Gymnodimine (GYM) Metabolite</th><th>Compound Identification Number (ID)</th><th>Carboxyl Group of the Ester (Carbon:Unsaturation)</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td>10-O-nonadecadienoyl-GYM-A</td><td>#111</td><td>19:2</td><td>C<sub>51</sub>H<sub>77</sub>NO<sub>5</sub></td><td>783.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-eicosanoyl-GYM-A</td><td>#112</td><td>20:0</td><td>C<sub>52</sub>H<sub>83</sub>NO<sub>5</sub></td><td>801.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-eicosenoyl-GYM-A</td><td>#113</td><td>20:1</td><td>C<sub>52</sub>H<sub>81</sub>NO<sub>5</sub></td><td>799.6</td><td>/</td><td>Clams (Ruditapes decussatus; Antigona lamellaris); Pen shell (Atrina pectinata); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-eicosadienoyl-GYM-A</td><td>#114</td><td>20:2</td><td>C<sub>52</sub>H<sub>79</sub>NO<sub>5</sub></td><td>797.6</td><td>/</td><td>Clams (Ruditapes decussatus, Antigona lamellaris); Pen shell (Atrina pectinata); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-eicosatrienoyl-GYM-A</td><td>#115</td><td>20:3</td><td>C<sub>52</sub>H<sub>77</sub>NO<sub>5</sub></td><td>795.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-eicosatetraenoyl-GYM-A</td><td>#116</td><td>20:4</td><td>C<sub>52</sub>H<sub>75</sub>NO<sub>5</sub></td><td>793.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-eicosapentaenoyl-GYM-A</td><td>#117</td><td>20:5</td><td>C<sub>52</sub>H<sub>72</sub>NO<sub>5</sub></td><td>790.5</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-heneicosanoyl-GYM-A</td><td>#118</td><td>21:0</td><td>C<sub>53</sub>H<sub>85</sub>NO<sub>5</sub></td><td>815.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heneicosenoyl-GYM-A</td><td>#119</td><td>21:1</td><td>C<sub>53</sub>H<sub>83</sub>NO<sub>5</sub></td><td>813.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heneicosadienoyl-GYM-A</td><td>#120</td><td>21:2</td><td>C<sub>53</sub>H<sub>81</sub>NO<sub>5</sub></td><td>811.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heneicosatrienoyl-GYM-A</td><td>#121</td><td>21:3</td><td>C<sub>53</sub>H<sub>79</sub>NO<sub>5</sub></td><td>809.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heneicosatetraenoyl-GYM-A</td><td>#122</td><td>21:4</td><td>C<sub>53</sub>H<sub>77</sub>NO<sub>5</sub></td><td>807.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-heneicosapentaenoyl-GYM-A</td><td>#123</td><td>21:5</td><td>C<sub>53</sub>H<sub>75</sub>NO<sub>5</sub></td><td>805.6</td><td>/</td><td>Mussels (M. galloprovincialis)</td><td>[41]</td></tr><tr><td>10-O-docosanoyl-GYM-A</td><td>#124</td><td>22:0</td><td>C<sub>54</sub>H<sub>87</sub>NO<sub>5</sub></td><td>829.7</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-docosenoyl-GYM-A</td><td>#125</td><td>22:1</td><td>C<sub>54</sub>H<sub>85</sub>NO<sub>5</sub></td><td>827.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr></tbody></table>
<table><caption>Table 3. *Cont.*</caption><thead><tr><th>Gymnodimine (GYM) Metabolite</th><th>Compound Identification Number (ID)</th><th>Carboxyl Group of the Ester (Carbon:Unsaturation)</th><th>Molecular Formula</th><th>Monoisotopic Mass (Da)</th><th>LogP <sup>1</sup></th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td>10-O-docosadienoyl-GYM-A</td><td>#126</td><td>22:2</td><td>C<sub>54</sub>H<sub>83</sub>NO<sub>5</sub></td><td>825.6</td><td>/</td><td>Clams (Ruditapes decussatus, Antigona lamellaris); Pen shell (Atrina pectinata); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-docosatrienoyl-GYM-A</td><td>#127</td><td>22:3</td><td>C<sub>54</sub>H<sub>81</sub>NO<sub>5</sub></td><td>823.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-docosatetraenoyl-GYM-A</td><td>#128</td><td>22:4</td><td>C<sub>54</sub>H<sub>79</sub>NO<sub>5</sub></td><td>821.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-docosapentaenoyl-GYM-A</td><td>#129</td><td>22:5</td><td>C<sub>54</sub>H<sub>77</sub>NO<sub>5</sub></td><td>819.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-docosahexaenoyl-GYM-A</td><td>#130</td><td>22:6</td><td>C<sub>54</sub>H<sub>75</sub>NO<sub>5</sub></td><td>817.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-tetracosanoyl-GYM-A</td><td>#131</td><td>24:0</td><td>C<sub>56</sub>H<sub>91</sub>NO<sub>5</sub></td><td>857.7</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-tetracosenoyl-GYM-A</td><td>#132</td><td>24:1</td><td>C<sub>56</sub>H<sub>89</sub>NO<sub>5</sub></td><td>855.7</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>10-O-tetracosapentaenoyl-GYM-A</td><td>#133</td><td>24:5</td><td>C<sub>56</sub>H<sub>81</sub>NO<sub>5</sub></td><td>847.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>10-O-tetracosahexaenoyl-GYM-A</td><td>#134</td><td>24:6</td><td>C<sub>56</sub>H<sub>79</sub>NO<sub>5</sub></td><td>845.6</td><td>/</td><td>Clams (Ruditapes decussatus); Mussels (M. galloprovincialis)</td><td>[41,42]</td></tr><tr><td>O-octadecanoyl-GYM-B</td><td>#135</td><td>18:0</td><td>C<sub>50</sub>H<sub>79</sub>NO<sub>6</sub></td><td>789.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr><tr><td>O-octadecanoyl-GYM-C</td><td>#136</td><td>18:0</td><td>C<sub>50</sub>H<sub>79</sub>NO<sub>6</sub></td><td>789.6</td><td>/</td><td>Clams (Ruditapes decussatus)</td><td>[42]</td></tr></tbody></table>

<footnote n="1">¹ LogP predicted from the chemical structure of molecules using the ACD/Labs platform. Octanol/water partition coefficient are predicted using algorithms.</footnote>
<figure><img src="image_25.png" /><figcaption>**10-O-Acyl-GYM-A**
R: Acyl ranging from C12 to C24 (ID #89 to #134)</figcaption></figure>

<figure><img src="image_26.png" /></figure>

Acyl position unknown: R₁, R₂ or R₃

<table><caption>**Figure 15.** Chemical structures of fatty acid conjugates of gymnodimines (GYMs).</caption><thead><tr><th>Gymnodimine analog</th><th>Compound ID</th><th>R<sub>1</sub></th><th>R<sub>2</sub></th><th>R<sub>3</sub></th></tr></thead><tbody><tr><td rowspan="2">O-octadecanoyl-GYM-B</td><td rowspan="2">#135</td><td>OH</td><td>H</td><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>16</sub>CO</td></tr><tr><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>16</sub>CO</td><td>H</td><td>OH</td></tr><tr><td rowspan="2">O-octadecanoyl-GYM-C</td><td rowspan="2">#136</td><td>H</td><td>OH</td><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>16</sub>CO</td></tr><tr><td>H</td><td>CH<sub>3</sub>(CH<sub>2</sub>)<sub>16</sub>CO</td><td>OH</td></tr></tbody></table>

**4. Accumulation and Biotransformation of Metabolites Produced by *Karenia* spp. in Other Marine Organisms**

Blooms of *K. brevis* are commonly associated with massive mortality for marine organisms. Massive death episodes of fish (prey fishes, sharks, rays), mammals (dolphins, manatees) or shorebirds, all occurring in Florida between 1999 and 2006, were associated with *K. brevis* blooms and the presence of BTXs [5,49,50,120]. Data regarding the accumulation and biotransformation of the other groups of toxins produced by *Karenia* spp. are lacking. In several studies, the implementation of biochemical methods of analysis, such as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), or receptor-binding assay (RBA), made it possible to measure high levels of BTX-like toxins in animal tissues, but did not enable identification of the specific nature of the BTX analogs. In a few studies conducted on samples collected in the Gulf of Mexico (Figure 1), LC-MS and LC-MS/MS analyses were implemented to obtain this information [2,48–50].

In fish, BTX-3 (ID #9) was identified in *Lagodon rhomboides* and *Leiostomus xanthurus*, whereas open A-ring BTX-3 (ID #16) and open A-ring BTX-7 (ID #7), not reported in shellfish to date, were also reported [48]. Among the amino-acid conjugates, cysteine-BTX-A (ID #53), cysteine BTX-A sulfoxide (ID #54), cysteine-BTX-B (ID #61) and cysteine-BTX-B sulfoxide (ID #62) were also identified in these fish species. From 301 live or dead sharks and rays from Florida, Flewelling at al. [49] studied the accumulation of BTXs. Some shark embryos were also included. For dead animals, the cause of their death was unknown but sometimes occurred during red-tide episodes of *K. brevis* blooms. Among these samples, a subset of liver and gill tissues were selected, and several metabolites were sought through LC-MS analysis (BTX-1, BTX-2, BTX-3, BTX-6, BTX-7, BTX-9, BTX-10, cysteine-BTX-B, cysteine-BTX-B sulfoxide and brevenal with respective ID numbers #1, #8, #9, #11, #2, #12, #3, #61, #62, #20). BTXs were detected in 26 of the 27 selected extracts. BTX-3 was quantified
in most of the liver and gill tissues (n = 21), whereas BTX-2 was only quantified in gills of two sharks. Cysteine-BTX-B and its sulfoxide were detected in 18 and 9 extracts of gills or livers, respectively.

After major dolphin (*Tursiops truncatus*) mortality events between 1999 and 2006 in Florida, BTXs and domoic acid (amnesic toxin produced by the *Pseudo-nitzschia* diatom) were sought in dead animals [50]. Of the 105 animals collected in 2004, 100% of the tested animals were positive for BTXs and 89% for domoic acid. Moreover, dolphin stomach contents frequently consisted of BTX-contaminated menhaden (*Brevoortia sp*.). For the period 2005–2006, 93% of the 90 dolphins were positive for BTXs, whereas domoic acid was not detected in these animals. Among the samples analyzed by LC-MS, BTX-3 (ID #9) was the predominant toxin in the four stomach contents tested (fishes partially digested) and was also detected in 10 of the 12 livers tested. Two peaks co-eluting with BTX-2 were not attributed to any known toxin.

An experimental study on shrimps (*Litopenaeus vannamei*) demonstrated that these marine organisms could represent a vector of BTXs [112]. The authors found by LC-MS levels of 80 and 90 µg eq BTX-2/kg in the digestive glands and muscles, respectively. It should be noted that this contamination started to appear in the digestive gland and the muscle after 30 and 45 days of exposure, respectively, and with relatively low cellular concentrations of *K. brevis* (10³ to 10⁶ cells/L). Macrobenthic invertebrates (including polychaetes and crustaceans belonging to amphipods and isopods) collected during a *K. brevis* bloom in Florida also demonstrated their capacity to accumulate BTXs [2]. However, the identity of the analogs was not determined due to the analytical tool implemented for the analysis (ELISA test).

**5. Conclusions**

In this review, we summarized and gathered the knowledge reported in the literature over recent decades of over 130 potentially toxic metabolites reported from *Karenia* spp. or metabolized by marine organisms. The structures and certain properties of these metabolites are presented. This information could constitute an interesting basis in view of library-building, particularly for physicochemical analysis using liquid chromatography combined with high-resolution mass spectrometry (LC-HRMS). Such an approach could be an interesting tool to simultaneously screen the different analogs mentioned here, and could also allow us to discover new analogs. The accumulation and biotransformation by marine organisms of the metabolites produced by *Karenia* spp. was also assessed in depth for BTXs and GYMs. We point out the need for more information on BTXs in marine organisms other than shellfish. Occurrence data would also be valuable for several groups of potentially toxic metabolites discovered in the last two decades. These data, combined with additional toxicology assays, could be used to carry out a risk assessment. Lastly, we compiled all the names reported for metabolites in the existing literature. Among the different nomenclatures, we tried to select the terms that allowed us to obtain a better overall consistency, hoping that this work will be useful to harmonize practices in the future.

**Author Contributions:** Z.A. and V.H. contributed equally to this manuscript. Conceptualization, V.H. and Z.A.; investigation, V.H. and Z.A.; writing—original draft preparation, V.H. and Z.A.; writing—review and editing, E.A., M.-Y.D.B., N.A., V.H. and Z.A.; visualization, V.H.; supervision, V.H. and Z.A. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Institutional Review Board Statement:** Not applicable.

**Informed Consent Statement:** Not applicable.

**Acknowledgments:** The authors sincerely thank the other experts who participated in the working group set up by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) to prevent health risks associated with the consumption of shellfish contaminated with
BTXs in France, that is to say: Katia Comte, Estelle Chaix, Nicolas Delcourt, César Mattei, Jordi Molgó and Raphaele Le Garrec.

**Conflicts of Interest:** The authors declare that they have no conflict of interest. Public DOIs are available on the following website: https://dpi.sante.gouv.fr/, accessed on 22 November 2021.

## References

1. Adl, S.M.; Bass, D.; Lane, C.E.; Lukeš, J.; Schoch, C.L.; Smirnov, A.; Agatha, S.; Berney, C.; Brown, M.W.; Burki, F.; et al. Revisions to the Classification, Nomenclature, and Diversity of Eukaryotes. *J. Eukaryot. Microbiol.* **2019**, *66*, 4–119. [CrossRef]

2. Bricelj, V.M.; Haubois, A.-G.; Sengco, M.R.; Pierce, R.H.; Culter, J.K.; Anderson, D.M. Trophic Transfer of Brevetoxins to the Benthic Macrofaunal Community during a Bloom of the Harmful Dinoflagellate Karenia Brevis in Sarasota Bay, Florida. *Harmful Algae* **2012**, *16*, 27–34. [CrossRef]

3. Brand, L.E.; Campbell, L.; Bresnan, E. Karenia: The Biology and Ecology of a Toxic Genus. *Harmful Algae* **2012**, *14*, 156–178. [CrossRef]

4. Plakas, S.M.; Dickey, R.W. Advances in Monitoring and Toxicity Assessment of Brevetoxins in Molluscan Shellfish. *Toxicon* **2010**, *56*, 137–149. [CrossRef] [PubMed]

5. Flewelling, L.J.; Naar, J.P.; Abbott, J.P.; Baden, D.G.; Barros, N.B.; Bossart, G.D.; Dechraoui Bottein, M.-Y.; Hammond, D.G.; Haubold, E.M.; Heil, C.A.; et al. Red Tides and Marine Mammal Mortalities. *Nature* **2005**, *435*, 755–756. [CrossRef] [PubMed]

6. Shen, M.; Xu, J.; Tsang, T.Y.; Au, D.W.T. Toxicity Comparison between Chattonella Marina and Karenia Brevis Using Marine Medaka (*Oryzias Melastigma*): Evidence against the Suspected Ichthyotoxins of Chattonella Marina. *Chemosphere* **2010**, *80*, 585–591. [CrossRef] [PubMed]

7. Berdalet, E.; Fleming, L.E.; Gowen, R.; Davidson, K.; Hess, P.; Backer, L.C.; Moore, S.K.; Hoagland, P.; Enevoldsen, H. Marine Harmful Algal Blooms, Human Health and Wellbeing: Challenges and Opportunities in the 21st Century. *J. Mar. Biol. Assoc. UK* **2016**, *96*, 61–91. [CrossRef] [PubMed]

8. Young, N.; Sharpe, R.A.; Barciela, R.; Nichols, G.; Davidson, K.; Berdalet, E.; Fleming, L.E. Marine Harmful Algal Blooms and Human Health: A Systematic Scoping Review. *Harmful Algae* **2020**, *98*, 101901. [CrossRef] [PubMed]

9. Watkins, S.M.; Reich, A.; Fleming, L.E.; Hammond, R. Neurotoxic Shellfish Poisoning. *Mar. Drugs* **2008**, *6*, 431–455. [CrossRef]

10. Amzil, Z.; Derrien, A.; Terre Terrillon, A.; Duval, A.; Connes, C.; Marco-Miralles, F.; Nézan, E.; Mertens, K.N. Monitoring the Emergence of Algal Toxins in Shellfish: First Report on Detection of Brevetoxins in French Mediterranean Mussels. *Mar. Drugs* **2021**, *19*, 393. [CrossRef]

11. Arnich, N.; Abadie, E.; Amzil, Z.; Dechraoui Bottein, M.-Y.; Comte, K.; Chaix, E.; Delcourt, N.; Hort, V.; Mattei, C.; Molgó, J.; et al. Guidance Level for Brevetoxins in French Shellfish. *Mar. Drugs* **2021**, *19*, 520. [CrossRef]

12. Caruana, A.M.N.; Amzil, Z. Chapter 13—Microalgae and Toxins. In *Microalgae in Health and Disease Prevention*; Levine, I.A., Fleurence, J., Eds.; Academic Press: Cambridge, MA, USA, 2018; pp. 263–305. ISBN 978-0-12-811405-6.

13. Baden, D.G. Brevetoxins: Unique Polyether Dinoflagellate Toxins. *FASEB J.* **1989**, *3*, 1807–1817. [CrossRef] [PubMed]

14. Poli, M.A.; Mende, T.J.; Baden, D.G. Brevetoxins, Unique Activators of Voltage-Sensitive Sodium Channels, Bind to Specific Sites in Rat Brain Synaptosomes. *Mol. Pharm.* **1986**, *30*, 129–135.

15. Daugbjerg, N.; Hansen, G.; Larsen, J.; Moestrup, Ø. Phylogeny of Some of the Major Genera of Dinoflagellates Based on Ultrastructure and Partial LSU rDNA Sequence Data, Including the Erection of Three New Genera of Unarmoured Dinoflagellates. *Phycologia* **2000**, *39*, 302–317. [CrossRef]

16. Shen, H.; Song, X.; Zhang, Y.; Zhang, P.; Li, J.; Song, W.; Yu, Z. Profiling of Brevetoxin Metabolites Produced by Karenia Brevis 165 Based on Liquid Chromatography-Mass Spectrometry. *Toxins* **2021**, *13*, 354. [CrossRef]

17. Abraham, A.; Flewelling, L.J.; El Said, K.R.; Odom, W.; Geiger, S.P.; Granholm, A.A.; Jackson, J.T.; Bodager, D. An Occurrence of Neurotoxic Shellfish Poisoning by Consumption of Gastropods Contaminated with Brevetoxins. *Toxicon* **2021**, *191*, 9–17. [CrossRef] [PubMed]

18. Abraham, A.; El Said, K.R.; Flewelling, L.J. Role of Biomarkers in Monitoring Brevetoxins in Karenia Brevis Exposed Shellfish. *Food Saf.* **2018**, *6*, 33–43. [CrossRef] [PubMed]

19. EFSA Panel on Contaminants in the Food Chain (CONTAM). Scientific Opinion on Marine Biotoxins in Shellfish—Emerging Toxins: Brevetoxin Group. *EFSA J. Food Saf.* **2010**, *8*, 1677. [CrossRef]

20. Nozawa, A.; Tsuji, K.; Ishida, H. Implication of Brevetoxin B1 and PbTx-3 in Neurotoxic Shellfish Poisoning in New Zealand by Isolation and Quantitative Determination with Liquid Chromatography-Tandem Mass Spectrometry. *Toxicon* **2003**, *42*, 91–103. [CrossRef]

21. Ishida, H.; Muramatsu, N.; Nukaya, H.; Kosuge, T.; Tsuji, K. Study on Neurotoxic Shellfish Poisoning Involving the Oyster, Crassostrea Gigas, in New Zealand. *Toxicon* **1996**, *34*, 1050–1053. [CrossRef]

22. Abraham, A.; Wang, Y.; El Said, K.R.; Plakas, S.M. Characterization of Brevetoxin Metabolism in Karenia Brevis Bloom-Exposed Clams (*Mercenaria* sp.) by LC-MS/MS. *Toxicon* **2012**, *60*, 1030–1040. [CrossRef] [PubMed]

23. Abraham, A.; El Said, K.R.; Wang, Y.; Jester, E.L.E.; Plakas, S.M.; Flewelling, L.J.; Henry, M.S.; Pierce, R.H. Biomarkers of Brevetoxin Exposure and Composite Toxin Levels in Hard Clam (*Mercenaria* sp.) Exposed to Karenia Brevis Blooms. *Toxicon* **2015**, *96*, 82–88. [CrossRef] [PubMed]
24. Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H.F.; Yasumoto, T. Gymnodimine, a New Marine Toxin of Unprecedented Structure Isolated from New Zealand Oysters and the Dinoflagellate, Gymnodinium sp. *Tetrahedron Lett.* **1995**, *36*, 7093–7096. [CrossRef]

25. Ben Naila, I.; Hamza, A.; Gdoura, R.; Diogène, J.; de la Iglesia, P. Prevalence and Persistence of Gymnodimines in Clams from the Gulf of Gabes (Tunisia) Studied by Mouse Bioassay and LC-MS/MS. *Harmful Algae* **2012**, *18*, 56–64. [CrossRef]

26. Marrouchi, R.; Dziri, F.; Belayouni, N.; Hamza, A.; Benoit, E.; Molgó, J.; Kharrat, R. Quantitative Determination of Gymnodimine-A by High Performance Liquid Chromatography in Contaminated Clams from Tunisia Coastline. *Mar. Biotechnol.* **2010**, *12*, 579–585. [CrossRef]

27. Biré, R.; Krys, S.; Frémy, J.-M.; Dragacci, S.; Stirling, D.; Kharrat, R. First Evidence on Occurrence of Gymnodimine in Clams from Tunisia. *J. Nat. Toxins* **2002**, *11*, 269–275.

28. Plakas, S.M.; El Said, K.R.; Jester, E.L.E.; Ray Granade, H.; Musser, S.M.; Dickey, R.W. Confirmation of Brevetoxin Metabolism in the Eastern Oyster (*Crassostrea Virginica*) by Controlled Exposures to Pure Toxins and to Karenia Brevis Cultures. *Toxicon* **2002**, *40*, 721–729. [CrossRef]

29. Poli, M.A.; Musser, S.M.; Dickey, R.W.; Eilers, P.P.; Hall, S. Neurotoxic Shellfish Poisoning and Brevetoxin Metabolites: A Case Study from Florida. *Toxicon* **2000**, *38*, 981–993. [CrossRef]

30. Dickey, R.; Jester, E.; Granade, R.; Mowdy, D.; Moncreiff, C.; Rebarchik, D.; Robl, M.; Musser, S.; Poli, M. Monitoring Brevetoxins during a Gymnodinium Breve Red Tide: Comparison of Sodium Channel Specific Cytotoxicity Assay and Mouse Bioassay for Determination of Neurotoxic Shellfish Toxins in Shellfish Extracts. *Nat. Toxins* **1999**, *7*, 157–165. [CrossRef]

31. Ishida, H.; Nozawa, A.; Nukaya, H.; Tsuji, K. Comparative Concentrations of Brevetoxins PbTx-2, PbTx-3, BTX-B1 and BTX-B5 in Cockle, Austrovenus Stutchburyi, Greenshell Mussel, Perna Canaliculus, and Pacific Oyster, Crassostrea Gigas, Involved Neurotoxic Shellfish Poisoning in New Zealand. *Toxicon* **2004**, *43*, 779–789. [CrossRef]

32. Ishida, H.; Nozawa, A.; Nukaya, H.; Rhodes, L.; McNabb, P.; Holland, P.T.; Tsuji, K. Confirmation of Brevetoxin Metabolism in Cockle, Austrovenus Stutchburyi, and Greenshell Mussel, Perna Canaliculus, Associated with New Zealand Neurotoxic Shellfish Poisoning, by Controlled Exposure to Karenia Brevis Culture. *Toxicon* **2004**, *43*, 701–712. [CrossRef] [PubMed]

33. Ishida, H.; Nozawa, A.; Hamano, H.; Naoki, H.; Fujita, T.; Kaspar, H.F.; Tsuji, K. Brevetoxin B5, a New Brevetoxin Analog Isolated from Cockle Austrovenus Stutchburyi in New Zealand, the Marker for Monitoring Shellfish Neurotoxicity. *Tetrahedron Lett.* **2004**, *45*, 29–33. [CrossRef]

34. Plakas, S.M.; Wang, Z.; El Said, K.R.; Jester, E.L.E.; Granade, H.R.; Flewelling, L.; Scott, P.; Dickey, R.W. Brevetoxin Metabolism and Elimination in the Eastern Oyster (*Crassostrea Virginica*) after Controlled Exposures to Karenia Brevis. *Toxicon* **2004**, *44*, 677–685. [CrossRef] [PubMed]

35. Abraham, A.; Plakas, S.M.; Wang, Z.; Jester, E.L.E.; El Said, K.R.; Granade, H.R.; Henry, M.S.; Blum, P.C.; Pierce, R.H.; Dickey, R.W. Characterization of Polar Brevetoxin Derivatives Isolated from Karenia Brevis Cultures and Natural Blooms. *Toxicon* **2006**, *48*, 104–115. [CrossRef] [PubMed]

36. Morohashi, A.; Satake, M.; Murata, K.; Naoki, H.; Kaspar, H.F.; Yasumoto, T. Brevetoxin B3, a New Brevetoxin Analog Isolated from the Greenshell Mussel Perna Canaliculus Involved in Neurotoxic Shellfish Poisoning in New Zealand. *Tetrahedron Lett.* **1995**, *36*, 8995–8998. [CrossRef]

37. Ishida, H.; Nozawa, A.; Totoribe, K.; Muramatsu, N.; Nukaya, H.; Tsuji, K.; Yamaguchi, K.; Yasumoto, T.; Kaspar, H.; Berkett, N.; et al. Brevetoxin B1, a New Polyether Marine Toxin from the New Zealand Shellfish, Austrovenus Stutchburyi. *Tetrahedron Lett.* **1995**, *36*, 725–728. [CrossRef]

38. Murata, K.; Satake, M.; Naoki, H.; Kaspar, H.F.; Yasumoto, T. Isolation and Structure of a New Brevetoxin Analog, Brevetoxin B2, from Greenshell Mussels from New Zealand. *Tetrahedron* **1998**, *54*, 735–742. [CrossRef]

39. Wang, Z.; Plakas, S.M.; El Said, K.R.; Jester, E.L.E.; Granade, H.R.; Dickey, R.W. LC/MS Analysis of Brevetoxin Metabolites in the Eastern Oyster (*Crassostrea Virginica*). *Toxicon* **2004**, *43*, 455–465. [CrossRef]

40. Morohashi, A.; Satake, M.; Naoki, H.; Kaspar, H.F.; Oshima, Y.; Yasumoto, T. Brevetoxin B4 Isolated from Greenshell Mussels. Perna Canaliculus, the Major Toxin Involved in Neurotoxic Shellfish Poisoning in New Zealand. *Nat. Toxins* **1999**, *7*, 45–48. [CrossRef]

41. Ji, Y.; Che, Y.; Wright, E.J.; McCarron, P.; Hess, P.; Li, A. Fatty Acid Ester Metabolites of Gymnodimine in Shellfish Collected from China and in Mussels (*Mytilus Galloprovincialis*) Exposed to Karenia Selliformis. *Harmful Algae* **2020**, *92*, 101774. [CrossRef]

42. De la Iglesia, P.; McCarron, P.; Diogène, J.; Quilliam, M.A. Discovery of Gymnodimine Fatty Acid Ester Metabolites in Shellfish Using Liquid Chromatography/Mass Spectrometry. *Rapid Commun. Mass Spectrom.* **2013**, *27*, 643–653. [CrossRef] [PubMed]

43. Li, A.; Sun, G.; Qiu, J.; Fan, L. Lipophilic Shellfish Toxins in Dinophysis Caudata Picked Cells and in Shellfish from the East China Sea. *Environ. Sci. Pollut. Res.* **2015**, *22*, 3116–3126. [CrossRef] [PubMed]

44. Liu, R.; Liang, Y.; Wu, X.; Xu, D.; Liu, Y.; Liu, L. First Report on the Detection of Pectenotoxin Groups in Chinese Shellfish by LC-MS/MS. *Toxicon* **2011**, *57*, 1000–1007. [CrossRef] [PubMed]

45. Jiang, T.; Liu, L.; Li, Y.; Zhang, J.; Tan, Z.; Wu, H.; Jiang, T.; Lu, S. Occurrence of Marine Algal Toxins in Oyster and Phytoplankton Samples in Daya Bay, South China Sea. *Chemosphere* **2017**, *183*, 80–88. [CrossRef] [PubMed]

46. Takahashi, E.; Yu, Q.; Eaglesham, G.; Connell, D.W.; McBroom, J.; Costanzo, S.; Shaw, G.R. Occurrence and Seasonal Variations of Algal Toxins in Water, Phytoplankton and Shellfish from North Stradbroke Island, Queensland, Australia. *Mar. Environ. Res.* **2007**, *64*, 429–442. [CrossRef]
47. Krock, B.; Pitcher, G.C.; Ntuli, J.; Cembella, A.D. Confirmed Identification of Gymnodimine in Oysters from the West Coast of South Africa by Liquid Chromatography-Tandem Mass Spectrometry. *Afr. J. Mar. Sci.* **2009**, *31*, 113–118. [CrossRef]

48. Fire, S.E.; Flewelling, L.J.; Naar, J.; Twiner, M.J.; Henry, M.S.; Pierce, R.H.; Gannon, D.P.; Wang, Z.; Davidson, L.; Wells, R.S. Prevalence of Brevetoxins in Prey Fish of Bottlenose Dolphins in Sarasota Bay, Florida. *Mar. Ecol. Prog. Ser.* **2008**, *368*, 283–294. [CrossRef]

49. Flewelling, L.; Adams, D.; Naar, J.; Atwood, K.; Granholm, A.; O'Dea, S.; Landsberg, J. Brevetoxins in Sharks and Rays (*Chondrichthyes, Elasmobranchii*) from Florida Coastal Waters. *Mar. Biol.* **2010**, *157*, 1937–1953. [CrossRef]

50. Twiner, M.J.; Flewelling, L.J.; Fire, S.E.; Bowen-Stevens, S.R.; Gaydos, J.K.; Johnson, C.K.; Landsberg, J.H.; Leighfield, T.A.; Mase-Guthrie, B.; Schwacke, L.; et al. Comparative Analysis of Three Brevetoxin-Associated Bottlenose Dolphin (*Tursiops truncatus*) Mortality Events in the Florida Panhandle Region (USA). *PLoS ONE* **2012**, *7*, e42974. [CrossRef]

51. Radwan, F.F.Y.; Ramsdell, J.S. Characterization of In Vitro Oxidative and Conjugative Metabolic Pathways for Brevetoxin (PbTx-2). *Toxicol. Sci.* **2006**, *89*, 57–65. [CrossRef]

52. Guo, F.; An, T.; Rein, K.S. Human Metabolites of Brevetoxin PbTx-2: Identification and Confirmation of Structure. *Toxicon* **2010**, *56*, 648–651. [CrossRef] [PubMed]

53. Gawley, R.E.; Rein, K.S.; Jeglitsch, G.; Adams, D.J.; Theodorakis, E.A.; Tiebes, J.; Nicolaou, K.C.; Baden, D.G. The Relationship of Brevetoxin 'Length' and A-Ring Functionality to Binding and Activity in Neuronal Sodium Channels. *Chem. Biol.* **1995**, *2*, 533–541. [CrossRef]

54. Jeglitsch, G.; Rein, K.; Baden, D.G.; Adams, D.J. Brevetoxin-3 (PbTx-3) and Its Derivatives Modulate Single Tetrodotoxin-Sensitive Sodium Channels in Rat Sensory Neurons. *J. Pharm. Exp. 1998*, *284*, 516–525.

55. Purkerson-Parker, S.L.; Fieber, L.A.; Rein, K.S.; Podona, T.; Baden, D.G. Brevetoxin Derivatives That Inhibit Toxin Activity. *Chem. Biol.* **2000**, *7*, 385–393. [CrossRef]

56. Satake, M.; Shoji, M.; Oshima, Y.; Naoki, H.; Fujita, T.; Yasumoto, T. Gymnocin-A, a Cytotoxic Polyether from the Notorious Red Tide Dinoflagellate, Gymnodinium Mikimotoi. *Tetrahedron Lett.* **2002**, *43*, 5829–5832. [CrossRef]

57. Satake, M.; Tanaka, Y.; Ishikura, Y.; Oshima, Y.; Naoki, H.; Yasumoto, T. Gymnocin-B with the Largest Contiguous Polyether Rings from the Red Tide Dinoflagellate, Karenia (Formerly Gymnodinium) Mikimotoi. *Tetrahedron Lett.* **2005**, *46*, 3537–3540. [CrossRef]

58. Tanaka, Y.; Satake, M.; Yotsu-Yamashita, M.; Oshima, Y. Gymnocin-A Carboxylic Acid and Gymnocin-A2, Cytotoxic Polyethers from the Red Tide Dinoflagellate Karenia Mikimotoi. *Heterocycles* **2013**, *87*, 2037–2046. [CrossRef]

59. Miles, C.O.; Wilkins, A.L.; Stirling, D.J.; MacKenzie, A.L. Gymnodimine C, an Isomer of Gymnodimine B, from Karenia Selliformis. *J. Agric. Food Chem.* **2003**, *51*, 4838–4840. [CrossRef]

60. Shimizu, Y.; Chou, H.N.; Bando, H.; Duyne, G.V.; Clardy, J.C. Structure of Brevetoxin A (GB-1 Toxin), the Most Potent Toxin in the Florida Red Tide Organism Gymnodinium Breve (*Ptychodiscus Brevis*). *J. Am. Chem. Soc.* **1986**, *108*, 514–515. [CrossRef]

61. Baden, D.; Mende, T.J.; Trainer, V.L. Derivatized Brevetoxins and Their Use as Quantitative Tools in Detection. *Mycotoxins* **1988**, *1988*, 1–2. [CrossRef]

62. Baden, D.G. *Metabolism and Toxinology of the Marine Dinoflagellate, Gymnodinium Breve*; University of Miami: Coral Gables, FL, USA, 1977.

63. Catterall, W.A.; Risk, M. Toxin T46 from *Ptychodiscus Brevis* (Formerly *Gymnodinium Breve*) Enhances Activation of Voltage-Sensitive Sodium Channels by Veratridine. *Mol. Pharm.* **1981**, *19*, 345–348.

64. Lin, Y.Y.; Risk, M.; Ray, S.M.; Van Engen, D.; Clardy, J.; Golik, J.; James, J.C.; Nakanishi, K. Isolation and Structure of Brevetoxin B from the "Red Tide" Dinoflagellate *Ptychodiscus Brevis* (*Gymnodinium Breve*). *J. Am. Chem. Soc.* **1981**, *103*, 6773–6775. [CrossRef]

65. Baden, D.G.; Mende, T.J. Toxicity of Two Toxins from the Florida Red Tide Marine Dinoflagellate, *Ptychodiscus Brevis*. *Toxicon* **1982**, *20*, 457–461. [CrossRef]

66. Chou, H.-N.; Shimizu, Y. A New Polyether Toxin from Gymnodinium Breve Davis. *Tetrahedron Lett.* **1982**, *23*, 5521–5524. [CrossRef]

67. Chou, H.-N.; Shimizu, Y.; Van Duyne, G.; Clardy, J. Isolation and Structures of Two New Polycyclic Ethers from Gymnodinium Breve Davis (=*Ptychodiscus Brevis*). *Tetrahedron Lett.* **1985**, *26*, 2865–2868. [CrossRef]

68. Shimizu, Y. Recent progress in marine toxin research. *Pure Appl. Chem.* **1982**, *54*, 1973–1980. [CrossRef]

69. Prasad, A.V.K.; Shimizu, Y. The Structure of Hemibrevetoxin-B: A New Type of Toxin in the Gulf of Mexico Red Tide Organism. *J. Am. Chem. Soc.* **1989**, *111*, 6476–6477. [CrossRef]

70. Bourdelais, A.J.; Jacocks, H.M.; Wright, J.L.C.; Bigwarfe, P.M., Jr.; Baden, D.G. A New Polyether Ladder Compound Produced by the Dinoflagellate Karenia Brevis. *J. Nat. Prod.* **2005**, *68*, 2–6. [CrossRef]

71. Satake, M.; Bourdelais, A.J.; Van Wagoner, R.M.; Baden, D.G.; Wright, J.L.C. Brevisamide: An Unprecedented Monocyclic Ether Alkaloid from the Dinoflagellate Karenia Brevis That Provides a Potential Model for Ladder-Frame Initiation. *Org. Lett.* **2008**, *10*, 3465–3468. [CrossRef]

72. Satake, M.; Campbell, A.; Van Wagoner, R.M.; Bourdelais, A.J.; Jacocks, H.; Baden, D.G.; Wright, J.L.C. Brevisin: An Aberrant Polycyclic Ether Structure from the Dinoflagellate Karenia Brevis and Its Implications for Polyether Assembly. *J. Org. Chem.* **2009**, *74*, 989–994. [CrossRef]

73. Truxal, L.T.; Bourdelais, A.J.; Jacocks, H.; Abraham, W.M.; Baden, D.G. Characterization of Tamulamides A and B, Polyethers Isolated from the Marine Dinoflagellate Karenia Brevis. *J. Nat. Prod.* **2010**, *73*, 536–540. [CrossRef]
74. Miles, C.O.; Wilkins, A.L.; Stirling, D.J.; MacKenzie, A.L. New Analogue of Gymnodimine from a Gymnodinium Species. *J. Agric. Food Chem.* **2000**, *48*, 1373–1376. [CrossRef] [PubMed]

75. Satake, M.; Irie, R.; Holland, P.T.; Harwood, D.T.; Shi, F.; Itoh, Y.; Hayashi, F.; Zhang, H. Brevisulcenals-A1 and A2, Sulfate Esters of Brevisulcenals, Isolated from the Red Tide Dinoflagellate Karenia Brevisulcata. *Toxins* **2021**, *13*, 82. [CrossRef]

76. Hamamoto, Y.; Tachibana, K.; Holland, P.T.; Shi, F.; Beuzenberg, V.; Itoh, Y.; Satake, M. Brevisulcenal-F: A Polycyclic Ether Toxin Associated with Massive Fish-Kills in New Zealand. *J. Am. Chem. Soc.* **2012**, *134*, 4963–4968. [CrossRef] [PubMed]

77. Shi, F. *Chemical and Toxicological Investigation of the Toxic Dinoflagellate, Karenia Brevisulcata*; Lincoln University: Christchurch, New Zealand, 2012.

78. Satake, M.; Irie, R.; Hamamoto, Y.; Tachibana, K.; Holland, P.T.; Harwood, D.T.; Shi, F.; Beuzenberg, V.; Itoh, Y.; Hayashi, F.; et al. Brevisulcenal-G, -H, and -I, Polycyclic Ether Marine Toxins from the Dinoflagellate Karenia Brevisulcata. *Heterocycles* **2018**, *96*, 2096–2105. [CrossRef]

79. Suzuki, R.; Irie, R.; Harntaweesup, Y.; Tachibana, K.; Holland, P.T.; Harwood, D.T.; Shi, F.; Beuzenberg, V.; Itoh, Y.; Pascal, S.; et al. Brevisulcatic Acids, Marine Ladder-Frame Polyethers from the Red Tide Dinoflagellate Karenia Brevisulcata in New Zealand. *Org. Lett.* **2014**, *16*, 5850–5853. [CrossRef]

80. Irie, R.; Suzuki, R.; Kazuo, T.; Holland, P.; Harwood, T.D.; Shi, F.; McNabb, P.; Beuzenberg, V.; Hayashi, F.; Zhang, H.; et al. Brevisulcatic Acids from a Marine Microalgal Species Implicated in a Toxic Event in New Zealand. *Heterocycles* **2016**, *92*, 45. [CrossRef]

81. Bourdelais, A.J.; Campbell, S.; Jacocks, H.; Naar, J.; Wright, J.L.C.; Carsi, J.; Baden, D.G. Brevenal Is a Natural Inhibitor of Brevetoxin Action in Sodium Channel Receptor Binding Assays. *Cell. Mol. Neurobiol.* **2004**, *24*, 553–563. [CrossRef]

82. Holland, P.T.; Shi, F.; Satake, M.; Hamamoto, Y.; Ito, E.; Beuzenberg, V.; McNabb, P.; Munday, R.; Briggs, L.; Truman, P.; et al. Novel Toxins Produced by the Dinoflagellate Karenia Brevisulcata. *Harmful Algae* **2012**, *13*, 47–57. [CrossRef]

83. R Core Team. *R: A Language and Environment for Statistical Computing*; R Foundation for Statistical Computing: Vienna, Austria, 2020.

84. Hadley, W. *Ggplot2: Elegant Graphics for Data Analysis*; Springer: New York, NY, USA, 2016.

85. Fowler, N.; Tomas, C.; Baden, D.; Campbell, L.; Bourdelais, A. Chemical Analysis of Karenia Papilionacea. *Toxicon* **2015**, *101*, 85–91. [CrossRef]

86. Nakanishi, K. The Chemistry of Brevetoxins: A Review. *Toxicon* **1985**, *23*, 473–479. [CrossRef]

87. Van Wagoner, R.M.; Misner, I.; Tomas, C.R.; Wright, J.L.C. Occurrence of 12-Methylgymnodimine in a Spirolide-Producing Dinoflagellate Alexandrium Peruvianum and the Biogenetic Implications. *Tetrahedron Lett.* **2011**, *52*, 4243–4246. [CrossRef]

88. Baden, D.G.; Bourdelais, A.J.; Jacocks, H.; Michelliza, S.; Naar, J. Natural and Derivative Brevetoxins: Historical Background, Multiplicity, and Effects. *Environ. Health Perspect.* **2005**, *113*, 621–625. [CrossRef] [PubMed]

89. Baden, D.G.; Mende, T.J.; Szmant, A.M.; Trainer, V.L.; Edwards, R.A.; Roszell, L.E. Brevetoxin Binding: Molecular Pharmacology versus Immunoassay. *Toxicon* **1988**, *26*, 97–103. [CrossRef]

90. Abraham, W.M.; Bourdelais, A.J.; Sabater, J.R.; Ahmed, A.; Lee, T.A.; Serebriakov, I.; Baden, D.G. Airway Responses to Aerosolized Brevetoxins in an Animal Model of Asthma. *Am. J. Respir. Crit. Care Med.* **2005**, *171*, 26–34. [CrossRef]

91. Golik, J.; James, J.C.; Nakanishi, K.; Lin, Y.-Y. The Structure of Brevetoxin C. *Tetrahedron Lett.* **1982**, *23*, 2535–2538. [CrossRef]

92. Fuwa, H.; Ebine, M.; Bourdelais, A.J.; Baden, D.G.; Sasaki, M. Total Synthesis, Structure Revision, and Absolute Configuration of (–)-Brevenal. *J. Am. Chem. Soc.* **2006**, *128*, 16989–16999. [CrossRef]

93. Herrmann, A.T.; Martinez, S.R.; Zakarian, A. A Concise Asymmetric Total Synthesis of (+)-Brevisamide. *Org. Lett.* **2011**, *13*, 3636–3639. [CrossRef] [PubMed]

94. Sakai, T.; Fukuta, A.; Nakamura, K.; Nakano, M.; Mori, Y. Total Synthesis of Brevisamide Using an Oxiranyl Anion Strategy. *J. Org. Chem.* **2016**, *81*, 3799–3808. [CrossRef]

95. Lee, J.; Oh, H.-S.; Kang, H.-Y. A Formal Total Synthesis of (–)-Brevisamide, a Marine Monocyclic Ether Amide. *Tetrahedron Lett.* **2015**, *56*, 1099–1102. [CrossRef]

96. Van Wagoner, R.M.; Satake, M.; Bourdelais, A.J.; Baden, D.G.; Wright, J.L.C. Absolute Configuration of Brevisamide and Brevisin: Confirmation of a Universal Biosynthetic Process for Karenia Brevis Polyethers. *J. Nat. Prod.* **2010**, *73*, 1177–1179. [CrossRef]

97. Kuranaga, T.; Ohtani, N.; Tsatsumi, R.; Baden, D.G.; Wright, J.L.C.; Satake, M.; Tachibana, K. Total Synthesis of (–)-Brevisin: A Concise Synthesis of a New Marine Polycyclic Ether. *Org. Lett.* **2011**, *13*, 696–699. [CrossRef]

98. Tsukano, C.; Sasaki, M. Total Synthesis of Gymnocin-A. *J. Am. Chem. Soc.* **2003**, *125*, 14294–14295. [CrossRef]

99. Stewart, M.; Blunt, J.W.; Munro, M.H.; Robinson, W.T.; Hannah, D.J. The Absolute Stereochemistry of the New Zealand Shellfish Toxin Gymnodimine. *Tetrahedron Lett.* **1997**, *38*, 4889–4890. [CrossRef]

100. Medhioub, W.; Guéguen, M.; Lassus, P.; Bardouil, M.; Truquet, P.; Sibat, M.; Medhioub, N.; Soudant, P.; Kraiem, M.; Amzil, Z. Detoxification Enhancement in the Gymnodimine-Contaminated Grooved Carpet Shell, Ruditapes Decussatus (Linné). *Harmful Algae* **2010**, *9*, 200–207. [CrossRef]

101. Otero, A.; Chapela, M.-J.; Atanassova, M.; Vieites, J.M.; Cabado, A.G. Cyclic Imines: Chemistry and Mechanism of Action: A Review. *Chem. Res. Toxicol.* **2011**, *24*, 1817–1829. [CrossRef] [PubMed]

102. Harju, K.; Koskela, H.; Kremp, A.; Suikkanen, S.; de la Iglesia, P.; Miles, C.O.; Krock, B.; Vanninen, P. Identification of Gymnodimine D and Presence of Gymnodimine Variants in the Dinoflagellate Alexandrium Ostenfeldii from the Baltic Sea. *Toxicon* **2016**, *112*, 68–76. [CrossRef] [PubMed]
103. Strangman, W.; Anttila, M.; Tomas, C.; Wright, J.L.C. (5S)-5-[(4aR,8aS,9E,11S,13R,14S,16R,17R,19S)-11,19-Dihydroxy-8,10,13,16-Tetramethyl-18-Methylidene-3,4,5,6,8a,11,12,13,14,15,16,17,18,19,20,21-Hexadecahydro-2H-14,17-Epoxybenzo[2,3]Cyclohexadeca[1,2-b]Pyridine-7-Y]-3-Methylfuran-2(5H)-One (12-Methylgymnodimine B). *Molbank* **2016**, *2016*, M896. [CrossRef]

104. Zurhelle, C.; Nieva, J.; Tillmann, U.; Harder, T.; Krock, B.; Tebben, J. Identification of Novel Gymnodimines and Spirolides from the Marine Dinoflagellate Alexandrium Ostenfeldii. *Mar. Drugs* **2018**, *16*, 446. [CrossRef] [PubMed]

105. Salgado, P.; Riobó, P.; Rodríguez, F.; Franco, J.M.; Bravo, I. Differences in the Toxin Profiles of *Alexandrium Ostenfeldii* (*Dinophyceae*) Strains Isolated from Different Geographic Origins: Evidence of Paralytic Toxin, Spirolide, and Gymnodimine. *Toxicon* **2015**, *103*, 85-98. [CrossRef]

106. Munday, R.; Towers, N.R.; Mackenzie, L.; Beuzenberg, V.; Holland, P.T.; Miles, C.O. Acute Toxicity of Gymnodimine to Mice. *Toxicon* **2004**, *44*, 173-178. [CrossRef]

107. Kharrat, R.; Servent, D.; Girard, E.; Ouanounou, G.; Amar, M.; Marrouchi, R.; Benoit, E.; Molgó, J. The Marine Phycotoxin Gymnodimine Targets Muscular and Neuronal Nicotinic Acetylcholine Receptor Subtypes with High Affinity. *J. Neurochem.* **2008**, *107*, 952-963. [CrossRef]

108. Chang, F.H. *Gymnodinium Brevisulcatum* sp. Nov. (*Gymnodiniales, Dinophyceae*), a New Species Isolated from the 1998 Summer Toxic Bloom in Wellington Harbour, New Zealand. *Phycologia* **1999**, *38*, 377-384. [CrossRef]

109. Keyzers, R.A. *The Isolation of Biologically Active Secondary Metabolites from New Zealand Marine Organisms*; Victoria University: Wellington, New Zealand, 2003.

110. Harwood, D.T.; Shi, F.; Satake, M.; Holland, P.T. A Sensitive LC-MS/MS Assay for Brevisulcenal and Brevisulcatic Acid Toxins Produced by the *Dinoflagellate Karenia Brevisulcata*. *Toxicon* **2014**, *84*, 19-27. [CrossRef] [PubMed]

111. Naar, J.; Kuranek, J.; Weidner, A.; Flewelling, L.; Bourdelais, A.; Steidinger, K.; Baden, D.G. Brevetoxin Depuration in Shellfish via Production of Non-Toxic Metabolites: Consequences for Seafood Safety and the Environmental Fate of Biotoxins. *Harmful Algae* **2004**, *10*, 488-490.

112. Pérez Linares, J.; Ochoa, J.L.; Gago Martínez, A. Retention and Tissue Damage of PSP and NSP Toxins in Shrimp: Is Cultured Shrimp a Potential Vector of Toxins to Human Population? *Toxicon* **2009**, *53*, 185-195. [CrossRef]

113. Plakas, S.M.; Jester, E.L.E.; El Said, K.R.; Granade, H.R.; Abraham, A.; Dickey, R.W.; Scott, P.S.; Flewelling, L.J.; Henry, M.; Blum, P.; et al. Monitoring of Brevetoxins in the Karenia Brevis Bloom-Exposed Eastern Oyster (*Crassostrea Virginica*). *Toxicon* **2008**, *52*, 32-38. [CrossRef]

114. U.S. Food and Drug Administration (FDA). National Shellfish Sanitation Program (NSSP). Guide for the Control of Molluscan Shellfish. 2019; pp. 1-491. Available online: https://www.fda.gov/media/143238/download (accessed on 22 November 2021).

115. NSW Government. *Marine Biotoxin Management Plan—NSW Shellfish Program*; NSW Government: Newington, NSW, Australia, 2015; pp. 1-44. Available online: https://www.foodauthority.nsw.gov.au/sites/default/files/_Documents/industry/marine_biotoxin_management_plan.pdf (accessed on 11 November 2021).

116. Victorian Fisheries Authority. Marine Biotoxin Management Plan. Available online: https://vfa.vic.gov.au/aquaculture/publications/shellfish-quality-assurance/marine-biotoxin-management-plan (accessed on 2 September 2021).

117. McNabb, P.S.; Selwood, A.I.; Van Ginkel, R.; Boundy, M.; Holland, P.T. Determination of Brevetoxins in Shellfish by LC/MS/MS: Single-Laboratory Validation. *J. AOAC Int.* **2012**, *95*, 1097-1105. [CrossRef]

118. New Zealand Government. *Regulated Control Scheme—Bivalve Molluscan Shellfish for Human Consumption*; New Zealand Government: Wellington, New Zealand, 2021; pp. 1-68. Available online: https://www.mpi.govt.nz/dmsdocument/30282-Animal-Products-Notice-Regulated-Control-Scheme-Bivalve-Molluscan-Shellfish-for-Human-Consumption-2018 (accessed on 22 November 2021).

119. ANSES. *Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the State of Knowledge on Brevetoxins in Shellfish, Data on Toxicity, Occurrence and Brevetoxin-Producing Microalgae*; ANSES: Maisons-Alfort, France, 2021; pp. 1-18. Available online: https://www.anses.fr/en/system/files/ERCA2020SA0020EN.pdf (accessed on 22 November 2021).

120. Van Deventer, M.; Atwood, K.; Vargo, G.A.; Flewelling, L.J.; Landsberg, J.H.; Naar, J.P.; Stanek, D. Karenia Brevis Red Tides and Brevetoxin-Contaminated Fish: A High Risk Factor for Florida's Scavenging Shorebirds? *Botanica Marina* **2012**, *55*, 31-37. [CrossRef]